<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antihypertensive agents for preventing diabetic kidney disease - Lv, J - 2012 | Cochrane Library</title> <meta property="og:title" content="Antihypertensive agents for preventing diabetic kidney disease - Lv, J - 2012 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004136.pub3/references" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD004136.pub3" /> <meta name="citation_title" content="Antihypertensive agents for preventing diabetic kidney disease" /> <meta name="citation_author" content="Jicheng Lv" /> <meta name="citation_author_institution" content="The George Institute for Global Health" /> <meta name="citation_author" content="Vlado Perkovic" /> <meta name="citation_author_institution" content="The George Institute for Global Health" /> <meta name="citation_author" content="Celine V Foote" /> <meta name="citation_author_institution" content="The George Institute for Global Health" /> <meta name="citation_author" content="Maria E Craig" /> <meta name="citation_author_institution" content="University of New South Wales" /> <meta name="citation_author" content="Jonathan C Craig" /> <meta name="citation_author_institution" content="The Children&#39;s Hospital at Westmead" /> <meta name="citation_author" content="Giovanni FM Strippoli" /> <meta name="citation_author_email" content="strippoli@negrisud.it" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="12" /> <meta name="citation_doi" content="10.1002/14651858.CD004136.pub3" /> <meta name="citation_date" content="2012" /> <meta name="citation_online_date" content="2012/12/12" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004136.pub3/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004136.pub3/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004136.pub3/pdf/CDSR/CD004136/CD004136.pdf" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <meta name="citation_keywords" content="Albuminuria [prevention &amp; control]; Angiotensin Receptor Antagonists [*therapeutic use]; Angiotensin‐Converting Enzyme Inhibitors [*therapeutic use]; Antihypertensive Agents [*therapeutic use]; Calcium Channel Blockers [*therapeutic use]; Diabetic Nephropathies [*prevention &amp; control]; Hypertension [drug therapy]; Randomized Controlled Trials as Topic" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <script type="text/javascript">var o={auth:{customerIds:["P#DRAAEAC","EAL00000056729","DRAA3TITLES","TSINGH009S","EAL0001468","EAL00000045347"],individualId:null,brandedCustomer:"EAL0001468",roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-CN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_TW&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-TW" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1513680834000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581718256000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 13},getRevision:function(){return"605.1"},getVersion:function(){return"13.0"},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return true},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="EfT7x5RD";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dreferences\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004136\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004136\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article References"},article:{availableLanguage:["en","es","ko","ms","za","ja"],languageCode:"en",accessStatus:"licensed",doi:"10.1002/14651858.CD004136.pub3",title:"Antihypertensive agents for preventing diabetic kidney disease",firstPublishedDate:"Dec 12, 2012 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581422282000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-b0f13d7a13ebe8b0b1b00a9f0730a084926e292f.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1581422282000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7XGCZUQPW4C675JNSTYTLUDN7XB/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=EfT7x5RD&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004136.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004136.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<p class="auxiliary-menu-item access">Access provided by: <strong>Tsinghua University</strong></p>
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD004136.pub3/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD004136.pub3/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004136.pub3%2Freferences" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
<div class="access-provider-mobile">
<p class="access">Access provided by: <strong>Tsinghua University</strong></p>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
About the CDSR
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_34" role="presentation">
<a aria-labelledby="layout_34" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochrane&#x2e;org&#x2f;about-us" role="menuitem">
About Cochrane
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;hub&#x2e;wiley&#x2e;com&#x2f;docs&#x2f;cochrane-library&#x2f;cochrane-library-known-issues-DOC-16221&#x3f;referrer&#x3d;cochrane" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <section class="content-language-banner system-message-container" data-content-language="en" data-portal-language="en" style="display: none"> <div class="container"> <a href="#0" class="fa fa-times content-language-banner-close pull-right" aria-label="Close"></a> <i class="fa fa-globe" aria-hidden="true"></i> <div class="system-message-title">Content Language Selection</div> <div class="system-message-description">Your language preference is set to <strong class="language">English</strong>. Where translations are available, article sections will display in this language. Return to <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=reset-content-language&p_p_cacheability=cacheLevelPage" class="language secondary">English</a>.</div> </div> </section> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD004136.PUB3" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD004136.pub3/#" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <a id="read-comments-on-review" class="js-old-version-modal-trigger" data-new-version="" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/read-comments"> Read comments on this Review(1) </a> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004136.pub3/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh&quot;,&quot;title&quot;:&quot;概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004136.pub3/full"> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full#CD004136-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full#CD004136-sec1-0006"> Authors' conclusions </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full#CD004136-sec1-0001"> Background </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full#CD004136-sec1-0002"> Objectives </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full#CD004136-sec1-0003"> Methods </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full#CD004136-sec1-0004"> Results </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full#CD004136-sec1-0005"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/appendices#CD004136-sec1-0011"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/information#history"> History </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/information#keywords"> Keywords </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/table_n/CD004136StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/table_n/CD004136StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article class="information" data-article-id="CD004136.PUB3"> <header> <h1 class="publication-title"><h1 lang="en" class="publication-title">Antihypertensive agents for preventing diabetic kidney disease</h1></h1> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div><h2 class="title section-collapse-title"> References <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <section class="references bibliographies" id="references"> <section> <div class="section-header" id="CD004136-bbs1-0001"> <h3 class="title">References to studies included in this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD004136-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD004136-bbs1-0003">additional references</a></li> <li><a class="jump-to" href="#CD004136-bbs1-0004">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0001"> <div class="reference-title-banner"> <h4 class="title">ABCD‐2V Study 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0001"> <div class="citation-journal">Estacio RO, Coll JR, Tran ZV, Schrier RW. <span class="citation-title">Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes</span>. <span class="citation"> American Journal of Hypertension </span><span class="pubYear">2006</span>;<span class="volume">19</span>(12):1241‐8. [MEDLINE: 17161769] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17161769" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+intensive+blood+pressure+control+with+valsartan+on+urinary+albumin+excretion+in+normotensive+patients+with+type+2+diabetes+&author=RO+Estacio&author=JR+Coll&author=ZV+Tran&author=RW+Schrier&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0002"> <div class="citation-journal">Estacio RO, Esler A, Lundgren R, Schrier RW. <span class="citation-title">Aggressive blood pressure control with valsartan in normotensive Type 2 diabetic patients results in regression of albuminuria. [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2004</span>;<span class="volume">15</span>(Oct):568A. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Aggressive+blood+pressure+control+with+valsartan+in+normotensive+Type+2+diabetic+patients+results+in+regression+of+albuminuria.+[abstract]+&author=RO+Estacio&author=A+Esler&author=R+Lundgren&author=RW+Schrier&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0002"> <div class="reference-title-banner"> <h4 class="title">ABCD Study 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0003"> <div class="citation-journal">Estacio RO, Jeffers B, Biggerstaff S, Schrier RW. <span class="citation-title">Effects of a calcium channel antagonist versus an ace inhibitor on diabetic nephropathy [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">1998</span>;<span class="volume">9</span>(Program &amp; Abstracts):114A. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+a+calcium+channel+antagonist+versus+an+ace+inhibitor+on+diabetic+nephropathy+[abstract]+&author=RO+Estacio&author=B+Jeffers&author=S+Biggerstaff&author=RW+Schrier&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0004"> <div class="citation-journal">Estacio RO, Jeffers BW, Gifford N, Schrier RW. <span class="citation-title">Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(Suppl 2):B54‐64. [MEDLINE: 10860192] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10860192" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+blood+pressure+control+on+diabetic+microvascular+complications+in+patients+with+hypertension+and+type+2+diabetes+&author=RO+Estacio&author=BW+Jeffers&author=N+Gifford&author=RW+Schrier&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0005"> <div class="citation-journal">Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. <span class="citation-title">The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1998</span>;<span class="volume">338</span>(10):645‐52. [MEDLINE: 9486993] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9486993" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+nisoldipine+as+compared+with+enalapril+on+cardiovascular+outcomes+in+patients+with+non%E2%80%90insulin%E2%80%90dependent+diabetes+and+hypertension+&author=RO+Estacio&author=BW+Jeffers&author=WR+Hiatt&author=SL+Biggerstaff&author=N+Gifford&author=RW+Schrier&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0006"> <div class="citation-journal">Estacio RO, Mehler P, Esler A, Schrier RW. <span class="citation-title">Aggressive lowering of blood pressure in normotensive type 2 diabetic patients: beneficial effects on stroke, progression of retinopathy and nephropathy [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2001</span>;<span class="volume">12</span>(Program &amp; Abstracts):146A. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Aggressive+lowering+of+blood+pressure+in+normotensive+type+2+diabetic+patients:+beneficial+effects+on+stroke,+progression+of+retinopathy+and+nephropathy+[abstract]+&author=RO+Estacio&author=P+Mehler&author=A+Esler&author=RW+Schrier&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0007"> <div class="citation-journal">Estacio RO, Savage S, Nagel NJ, Schrier RW. <span class="citation-title">Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial</span>. <span class="citation"> Controlled Clinical Trials </span><span class="pubYear">1996</span>;<span class="volume">17</span>(3):242‐57. [MEDLINE: 8877260] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8877260" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Baseline+characteristics+of+participants+in+the+Appropriate+Blood+Pressure+Control+in+Diabetes+trial+&author=RO+Estacio&author=S+Savage&author=NJ+Nagel&author=RW+Schrier&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0008"> <div class="citation-journal">Estacio RO, Schrier RW. <span class="citation-title">Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial</span>. <span class="citation"> American Journal of Cardiology </span><span class="pubYear">1998</span>;<span class="volume">82</span>(9B):9R‐14R. [MEDLINE: 9822137] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9822137" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antihypertensive+therapy+in+type+2+diabetes:+implications+of+the+appropriate+blood+pressure+control+in+diabetes+(ABCD)+trial+&author=RO+Estacio&author=RW+Schrier&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0009"> <div class="citation-journal">Savage S, Estacio RO, Jeffers B, Schrier RW. <span class="citation-title">Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1996</span>;<span class="volume">19</span>(11):1243‐8. [MEDLINE: 8908388] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8908388" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Urinary+albumin+excretion+as+a+predictor+of+diabetic+retinopathy,+neuropathy,+and+cardiovascular+disease+in+NIDDM+&author=S+Savage&author=RO+Estacio&author=B+Jeffers&author=RW+Schrier&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0010"> <div class="citation-journal">Schrier RW, Estacio RO, Esler A, Mehler P. <span class="citation-title">Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes</span>. <span class="citation"> Kidney International </span><span class="pubYear">2002</span>;<span class="volume">61</span>(3):1086‐97. [MEDLINE: 11849464] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11849464" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+aggressive+blood+pressure+control+in+normotensive+type+2+diabetic+patients+on+albuminuria,+retinopathy+and+strokes+&author=RW+Schrier&author=RO+Estacio&author=A+Esler&author=P+Mehler&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0011"> <div class="citation-journal">Schrier RW, Estacio RO, Jeffers B. <span class="citation-title">Appropriate Blood Pressure Control in NIDDM (ABCD) Trial</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1996</span>;<span class="volume">39</span>(12):1646‐54. [MEDLINE: 8960857] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8960857" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Appropriate+Blood+Pressure+Control+in+NIDDM+(ABCD)+Trial&author=RW+Schrier&author=RO+Estacio&author=B+Jeffers&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0012"> <div class="citation-journal">Stabler SP, Estacio R, Jeffers BW, Cohen JA, Allen RH, Schrier RW. <span class="citation-title">Total homocysteine is associated with nephropathy in non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Metabolism: Clinical &amp; Experimental </span><span class="pubYear">1999</span>;<span class="volume">48</span>(9):1096‐101. [MEDLINE: 10484047] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Total+homocysteine+is+associated+with+nephropathy+in+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus+&author=SP+Stabler&author=R+Estacio&author=BW+Jeffers&author=JA+Cohen&author=RH+Allen&author=RW+Schrier&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0003"> <div class="reference-title-banner"> <h4 class="title">ADVANCE Study 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0014"> <div class="citation-journal">ADVANCE Collaborative Group. <span class="citation-title">ADVANCE‐‐Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2005</span>;<span class="volume">22</span>(7):882‐8. [MEDLINE: 15975103] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15975103" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0013"> <div class="citation-journal">ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. <span class="citation-title">Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2008</span>;<span class="volume">358</span>(24):2560‐72. [MEDLINE: 18539916] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18539916" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intensive+blood+glucose+control+and+vascular+outcomes+in+patients+with+type+2+diabetes&author=A+Patel&author=S+MacMahon&author=J+Chalmers&author=B+Neal&author=L+Billot&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0015"> <div class="citation-journal">ADVANCE Management Committee. <span class="citation-title">Study rationale and design of ADVANCE: action in diabetics and vascular disease ‐ preterax and diamicron MR controlled evaluation</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2001</span>;<span class="volume">44</span>(9):1118‐20. [MEDLINE: 11596665] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11596665" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0016"> <div class="citation-journal">Anonymous. <span class="citation-title">Rationale and design of the ADVANCE study: a randomised trial of blood pressure lowering and intensive glucose control in high‐risk individuals with type 2 diabetes mellitus. Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified‐Release Controlled Evaluation</span>. <span class="citation"> Journal of Hypertension ‐ Supplement </span><span class="pubYear">2001</span>;<span class="volume">19</span>(4):S21‐8. [MEDLINE: 11848259] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rationale+and+design+of+the+ADVANCE+study:+a+randomised+trial+of+blood+pressure+lowering+and+intensive+glucose+control+in+high%E2%80%90risk+individuals+with+type+2+diabetes+mellitus.+Action+in+Diabetes+and+Vascular+Disease:+PreterAx+and+DiamicroN+Modified%E2%80%90Release+Controlled+Evaluation+&author=+Anonymous&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0017"> <div class="citation-journal">Chalmers J. <span class="citation-title">ADVANCE Study: objectives, design and current status</span> [Etude ADVANCE : objectifs, protocole et état actuel]. <span class="citation"> Drugs </span><span class="pubYear">2003</span>;<span class="volume">63 Spec No. 1</span>:39‐44. [MEDLINE: 12708881] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12708881" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=ADVANCE+Study:+objectives,+design+and+current+status&author=J+Chalmers&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0018"> <div class="citation-journal">Heerspink HJ, Ninomiya T, Perkovic V, Woodward M, Zoungas S, Cass A, et al. <span class="citation-title">Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease</span>. <span class="citation"> European Heart Journal </span><span class="pubYear">2010</span>;<span class="volume">31</span>(23):2888‐96. [MEDLINE: 20501479] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20501479" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+a+fixed+combination+of+perindopril+and+indapamide+in+patients+with+type+2+diabetes+and+chronic+kidney+disease+&author=HJ+Heerspink&author=T+Ninomiya&author=V+Perkovic&author=M+Woodward&author=S+Zoungas&author=A+Cass&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0019"> <div class="citation-journal">Jardine M, Ninomiya T, Perkovic V, Woodward M, Pillai A, Cass A, et al. <span class="citation-title">Predictive baseline factors for major renal events: a proportional hazards model based on the Advance Study [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2008</span>;<span class="volume">19</span>(Abstracts Issue):543A. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Predictive+baseline+factors+for+major+renal+events:+a+proportional+hazards+model+based+on+the+Advance+Study+[abstract]+&author=M+Jardine&author=T+Ninomiya&author=V+Perkovic&author=M+Woodward&author=A+Pillai&author=A+Cass&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0020"> <div class="citation-journal">Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, et al. <span class="citation-title">Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial</span>. <span class="citation"> Journal of Hypertension </span><span class="pubYear">2010</span>;<span class="volume">28</span>(6):1141‐9. [MEDLINE: 20486273] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20486273" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+routine+blood+pressure+lowering+in+older+patients+with+diabetes:+results+from+the+ADVANCE+trial+&author=T+Ninomiya&author=S+Zoungas&author=B+Neal&author=M+Woodward&author=A+Patel&author=V+Perkovic&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0021"> <div class="citation-journal">Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, et al. <span class="citation-title">Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2007</span>;<span class="volume">370</span>(9590):829‐40. [MEDLINE: 17765963] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17765963" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+a+fixed+combination+of+perindopril+and+indapamide+on+macrovascular+and+microvascular+outcomes+in+patients+with+type+2+diabetes+mellitus+(the+ADVANCE+trial):+a+randomised+controlled+trial+&author=A+Patel&author=S+MacMahon&author=J+Chalmers&author=B+Neal&author=M+Woodward&author=L+Billot&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0022"> <div class="citation-other">Perkovic V, Ninomiya T, Galan BE, Zoungas S, Cass A, Patel A, et al. <span class="citation-title">Joint effects of routine blood pressure lowering and intensive glucose control in the ADVANCE trial [abstract no: LB‐002]</span>. American Society of Nephrology (ASN) Renal Week; 2008 Nov 4‐9; Philadelphia, PA. <span class="pubYear">2008</span>. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Joint+effects+of+routine+blood+pressure+lowering+and+intensive+glucose+control+in+the+ADVANCE+trial+[abstract+no:+LB%E2%80%90002]+&author=V+Perkovic&author=T+Ninomiya&author=BE+Galan&author=S+Zoungas&author=A+Cass&author=A+Patel&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0023"> <div class="citation-journal">Perkovic V, Zoungas S, Heerspink HL, Woodward M, Jun M, Cass A, et al. <span class="citation-title">Intensive glucose lowering and end stage kidney disease ‐ new data from the ADVANCE trial [abstract]</span>. <span class="citation"> Nephrology </span><span class="pubYear">2011</span>;<span class="volume">16</span>(Suppl 1):42. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intensive+glucose+lowering+and+end+stage+kidney+disease+%E2%80%90+new+data+from+the+ADVANCE+trial+[abstract]+&author=V+Perkovic&author=S+Zoungas&author=HL+Heerspink&author=M+Woodward&author=M+Jun&author=A+Cass&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0024"> <div class="citation-journal">Perkovic V, Galan B, Chalmers J, Ninomiya T, Patel A, Cass A, et al. <span class="citation-title">Renoprotection with perindopril‐indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: results of the ADVANCE trial [abstract]</span>. <span class="citation"> Nephrology </span><span class="pubYear">2008</span>;<span class="volume">13</span>(Suppl 3):A121. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renoprotection+with+perindopril%E2%80%90indapamide+below+current+recommended+blood+pressure+targets+in+patients+with+type+2+diabetes+mellitus:+results+of+the+ADVANCE+trial+[abstract]+&author=V+Perkovic&author=B+Galan&author=J+Chalmers&author=T+Ninomiya&author=A+Patel&author=A+Cass&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0025"> <div class="citation-journal">Poulter NR. <span class="citation-title">Blood pressure and glucose control in subjects with diabetes: new analyses from ADVANCE</span>. <span class="citation"> Journal of Hypertension ‐ Supplement </span><span class="pubYear">2009</span>;<span class="volume">27</span>(1):S3‐8. [MEDLINE: 19483505] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Blood+pressure+and+glucose+control+in+subjects+with+diabetes:+new+analyses+from+ADVANCE&author=NR+Poulter&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0026"> <div class="citation-journal">Zoungas S, Galan BE, Ninomiya T, Grobbee D, Hamet P, Heller S, et al. <span class="citation-title">Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2009</span>;<span class="volume">32</span>(11):2068‐74. [MEDLINE: 19651921] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19651921" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Combined+effects+of+routine+blood+pressure+lowering+and+intensive+glucose+control+on+macrovascular+and+microvascular+outcomes+in+patients+with+type+2+diabetes:+New+results+from+the+ADVANCE+trial+&author=S+Zoungas&author=BE+Galan&author=T+Ninomiya&author=D+Grobbee&author=P+Hamet&author=S+Heller&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0027"> <div class="citation-journal">Galan BE, Ninomiya T, Perrovic V, Pillai A, Patel A, Neal AC, et al. <span class="citation-title">Renoprotective effects of blood pressure lowering with perindopril‐indapamide below current targets in people with type 2 diabetes mellitus: Results of the ADVANCE trial [abstract]</span>. <span class="citation"> Diabetes </span><span class="pubYear">2008</span>;<span class="volume">57</span>(Suppl 1):A218‐9. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renoprotective+effects+of+blood+pressure+lowering+with+perindopril%E2%80%90indapamide+below+current+targets+in+people+with+type+2+diabetes+mellitus:+Results+of+the+ADVANCE+trial+[abstract]+&author=BE+Galan&author=T+Ninomiya&author=V+Perrovic&author=A+Pillai&author=A+Patel&author=AC+Neal&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0028"> <div class="citation-journal">Galan BE, Perkovic V, Ninomiya T, Pillai A, Patel A, Cass A, et al. <span class="citation-title">Lowering blood pressure reduces renal events in type 2 diabetes</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2009</span>;<span class="volume">20</span>(4):883‐92. [MEDLINE: 19225038] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19225038" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lowering+blood+pressure+reduces+renal+events+in+type+2+diabetes&author=BE+Galan&author=V+Perkovic&author=T+Ninomiya&author=A+Pillai&author=A+Patel&author=A+Cass&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0004"> <div class="reference-title-banner"> <h4 class="title">Baba 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0029"> <div class="citation-journal">Baba S, The J‐MIND Study Group. <span class="citation-title">Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics</span>. <span class="citation"> Diabetes Research &amp; Clinical Practice </span><span class="pubYear">2001</span>;<span class="volume">54</span>(3):191‐201. [MEDLINE: 11689274] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Nifedipine+and+enalapril+equally+reduce+the+progression+of+nephropathy+in+hypertensive+type+2+diabetics+&author=S+Baba&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0005"> <div class="reference-title-banner"> <h4 class="title">BENEDICT Study 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0030"> <div class="citation-journal">BENEDICT G. <span class="citation-title">The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics</span>. <span class="citation"> Controlled Clinical Trials </span><span class="pubYear">2003</span>;<span class="volume">24</span>(4):442‐61. [MEDLINE: 12865039] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12865039" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+BErgamo+NEphrologic+DIabetes+Complications+Trial+(BENEDICT):+design+and+baseline+characteristics+&author=G+BENEDICT&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0031"> <div class="citation-journal">Cosmo S, Motterlini N, Prudente S, Pellegrini F, Trevisan R, Bossi A, et al. <span class="citation-title">Impact of the PPAR‐gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new‐onset microalbuminuria in type 2 diabetes: evidence from BENEDICT</span>. <span class="citation"> Diabetes </span><span class="pubYear">2009</span>;<span class="volume">58</span>(12):2920‐9. [MEDLINE: 19720797] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19720797" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Impact+of+the+PPAR%E2%80%90gamma2+Pro12Ala+polymorphism+and+ACE+inhibitor+therapy+on+new%E2%80%90onset+microalbuminuria+in+type+2+diabetes:+evidence+from+BENEDICT+&author=S+Cosmo&author=N+Motterlini&author=S+Prudente&author=F+Pellegrini&author=R+Trevisan&author=A+Bossi&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0032"> <div class="citation-journal">Remuzzi G, Macia M, Ruggenenti P. <span class="citation-title">Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2006</span>;<span class="volume">17</span>(4 Suppl 2):S90‐7. [MEDLINE: 16565256] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16565256" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prevention+and+treatment+of+diabetic+renal+disease+in+type+2+diabetes:+the+BENEDICT+study+&author=G+Remuzzi&author=M+Macia&author=P+Ruggenenti&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0033"> <div class="citation-journal">Ruggenenti P, Fassi A, Ilieva AP, Iliev IP, Chiurchiu C, Rubis N, et al. <span class="citation-title">Effects of verapamil added‐on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT‐B randomized trial</span>. <span class="citation"> Journal of Hypertension </span><span class="pubYear">2011</span>;<span class="volume">29</span>(2):207‐16. [MEDLINE: 21243736] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21243736" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+verapamil+added%E2%80%90on+trandolapril+therapy+in+hypertensive+type+2+diabetes+patients+with+microalbuminuria:+the+BENEDICT%E2%80%90B+randomized+trial+&author=P+Ruggenenti&author=A+Fassi&author=AP+Ilieva&author=IP+Iliev&author=C+Chiurchiu&author=N+Rubis&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0034"> <div class="citation-journal">Ruggenenti P, Fassi A, Parvanova Ilieva A, Bruno Petrov Iliev I, Brusegan V, Rubis N, et al. <span class="citation-title">Preventing microalbuminuria in type 2 diabetes</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2004</span>;<span class="volume">351</span>(19):1941‐51. [MEDLINE: 15516697] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15516697" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Preventing+microalbuminuria+in+type+2+diabetes&author=P+Ruggenenti&author=A+Fassi&author=A+ParvanovaIlieva&author=I+BrunoPetrovIliev&author=V+Brusegan&author=N+Rubis&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0035"> <div class="citation-journal">Ruggenenti P, Iliev I, Costa GM, Parvanova A, Perna A, Giuliano GA, et al. <span class="citation-title">Preventing left ventricular hypertrophy by ACE inhibition in hypertensive patients with type 2 diabetes: a prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2008</span>;<span class="volume">31</span>(8):1629‐34. [MEDLINE: 18443191] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18443191" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Preventing+left+ventricular+hypertrophy+by+ACE+inhibition+in+hypertensive+patients+with+type+2+diabetes:+a+prespecified+analysis+of+the+Bergamo+Nephrologic+Diabetes+Complications+Trial+(BENEDICT)+&author=P+Ruggenenti&author=I+Iliev&author=GM+Costa&author=A+Parvanova&author=A+Perna&author=GA+Giuliano&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0036"> <div class="citation-journal">Ruggenenti P, Perna A, Ganeva M, Ene‐Iordache B, Remuzzi G, BENEDICT Study Group. <span class="citation-title">Impact of blood pressure control and angiotensin‐converting enzyme inhibitor therapy on new‐onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2006</span>;<span class="volume">17</span>(12):3472‐81. [MEDLINE: 17082240] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17082240" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Impact+of+blood+pressure+control+and+angiotensin%E2%80%90converting+enzyme+inhibitor+therapy+on+new%E2%80%90onset+microalbuminuria+in+type+2+diabetes:+a+post+hoc+analysis+of+the+BENEDICT+trial+&author=P+Ruggenenti&author=A+Perna&author=M+Ganeva&author=B+Ene%E2%80%90Iordache&author=G+Remuzzi&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0037"> <div class="citation-journal">Ruggenenti P, Remuzzi G. <span class="citation-title">Primary prevention of renal failure in diabetic patients: the Bergamo Nephrologic Diabetes Complication Trial</span>. <span class="citation"> Journal of Hypertension ‐ Supplement </span><span class="pubYear">1998</span>;<span class="volume">16</span>(1):S95‐7. [MEDLINE: 9534106] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Primary+prevention+of+renal+failure+in+diabetic+patients:+the+Bergamo+Nephrologic+Diabetes+Complication+Trial+&author=P+Ruggenenti&author=G+Remuzzi&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0006"> <div class="reference-title-banner"> <h4 class="title">CALM II Study 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0038"> <div class="citation-journal">Andersen NH, Knudsen ST, Poulsen PL, Poulsen SH, Helleberg K, Eiskjaer H, et al. <span class="citation-title">Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design</span>. <span class="citation"> Journal of the Renin‐Angiotensin‐Aldosterone System </span><span class="pubYear">2003</span>;<span class="volume">4</span>(2):96‐9. [MEDLINE: 12806591] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12806591" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Dual+blockade+with+candesartan+cilexetil+and+lisinopril+in+hypertensive+patients+with+diabetes+mellitus:+rationale+and+design+&author=NH+Andersen&author=ST+Knudsen&author=PL+Poulsen&author=SH+Poulsen&author=K+Helleberg&author=H+Eiskjaer&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0039"> <div class="citation-journal">Andersen NH, Poulsen PL, Knudsen ST, Poulsen SH, Eiskjaer H, Hansen KW, et al. <span class="citation-title">Long‐term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>(2):273‐7. [MEDLINE: 15677778] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15677778" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+dual+blockade+with+candesartan+and+lisinopril+in+hypertensive+patients+with+diabetes:+the+CALM+II+study+&author=NH+Andersen&author=PL+Poulsen&author=ST+Knudsen&author=SH+Poulsen&author=H+Eiskjaer&author=KW+Hansen&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0040"> <div class="citation-journal">Knudsen ST, Andersen NH, Poulsen SH, Eiskjaer H, Hansen KW, Helleberg K, et al. <span class="citation-title">Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high‐dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post‐hoc analysis</span>. <span class="citation"> American Journal of Hypertension </span><span class="pubYear">2008</span>;<span class="volume">21</span>(2):172‐6. [MEDLINE: 18188164] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18188164" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pulse+pressure+lowering+effect+of+dual+blockade+with+candesartan+and+lisinopril+vs.+high%E2%80%90dose+ACE+inhibition+in+hypertensive+type+2+diabetic+subjects:+a+CALM+II+study+post%E2%80%90hoc+analysis+&author=ST+Knudsen&author=NH+Andersen&author=SH+Poulsen&author=H+Eiskjaer&author=KW+Hansen&author=K+Helleberg&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0007"> <div class="reference-title-banner"> <h4 class="title">Chan 1992 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0041"> <div class="citation-journal">Chan JC, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R. <span class="citation-title">Comparison of enalapril and nifedipine in treating non‐insulin dependent diabetes associated with hypertension: one year analysis</span>. <span class="citation"> BMJ </span><span class="pubYear">1992</span>;<span class="volume">305</span>(6860):981‐5. [MEDLINE: 1458144] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1458144" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+enalapril+and+nifedipine+in+treating+non%E2%80%90insulin+dependent+diabetes+associated+with+hypertension:+one+year+analysis+&author=JC+Chan&author=CS+Cockram&author=MG+Nicholls&author=CK+Cheung&author=R+Swaminathan&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0042"> <div class="citation-journal">Chan JC, Ko GT, Leung DH, Cheung RC, Cheung MY, So WY, et al. <span class="citation-title">Long‐term effects of angiotensin‐converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients</span>. <span class="citation"> Kidney International </span><span class="pubYear">2000</span>;<span class="volume">57</span>(2):590‐600. [MEDLINE: 10652036] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10652036" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+effects+of+angiotensin%E2%80%90converting+enzyme+inhibition+and+metabolic+control+in+hypertensive+type+2+diabetic+patients+&author=JC+Chan&author=GT+Ko&author=DH+Leung&author=RC+Cheung&author=MY+Cheung&author=WY+So&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0043"> <div class="citation-journal">Chan JC, Nicholls MG, Cheung CK, Law LK, Swaminathan R, Cockram CS. <span class="citation-title">Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1995</span>;<span class="volume">18</span>(7):1001‐6. [MEDLINE: 7555530] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7555530" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Factors+determining+the+blood+pressure+response+to+enalapril+and+nifedipine+in+hypertension+associated+with+NIDDM+&author=JC+Chan&author=MG+Nicholls&author=CK+Cheung&author=LK+Law&author=R+Swaminathan&author=CS+Cockram&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0044"> <div class="citation-journal">Chan JC, Yeung VT, Leung DH, Tomlinson B, Nicholls MG, Cockram CS. <span class="citation-title">The effects of enalapril and nifedipine on carbohydrate and lipid metabolism in NIDDM</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1994</span>;<span class="volume">17</span>(8):859‐62. [MEDLINE: 7956631] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/7956631" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+enalapril+and+nifedipine+on+carbohydrate+and+lipid+metabolism+in+NIDDM&author=JC+Chan&author=VT+Yeung&author=DH+Leung&author=B+Tomlinson&author=MG+Nicholls&author=CS+Cockram&publication_year=1994&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0008"> <div class="reference-title-banner"> <h4 class="title">Crepaldi 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0045"> <div class="citation-journal">Crepaldi G, Carraro A, Brocco E, Adezati L, Andreani D, Bompiani G, et al. <span class="citation-title">Hypertension and non‐insulin‐dependent diabetes</span>. <span class="citation"> Acta Diabetologica </span><span class="pubYear">1995</span>;<span class="volume">32</span>(3):203‐8. [MEDLINE: 8590792] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8590792" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Hypertension+and+non%E2%80%90insulin%E2%80%90dependent+diabetes&author=G+Crepaldi&author=A+Carraro&author=E+Brocco&author=L+Adezati&author=D+Andreani&author=G+Bompiani&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0009"> <div class="reference-title-banner"> <h4 class="title">DIRECT Studies 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0046"> <div class="citation-journal">Bilous R, Chaturvedi N, Sjolie AK, Fuller J, Klein R, Orchard T, et al. <span class="citation-title">Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">2009</span>;<span class="volume">151</span>(1):11‐20, W3‐4. [MEDLINE: 19451554] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19451554" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+candesartan+on+microalbuminuria+and+albumin+excretion+rate+in+diabetes:+three+randomized+trials+&author=R+Bilous&author=N+Chaturvedi&author=AK+Sjolie&author=J+Fuller&author=R+Klein&author=T+Orchard&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0047"> <div class="citation-journal">Bilous RW, Parving H, Nishi C. <span class="citation-title">DIRECT‐Renal: The effect of the angiotensive type 1 receptor blocker candesartan on the development of microalbuminuria in type 1 and type 2 diabetes [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2008</span>, (Abstracts Issue). <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=DIRECT%E2%80%90Renal:+The+effect+of+the+angiotensive+type+1+receptor+blocker+candesartan+on+the+development+of+microalbuminuria+in+type+1+and+type+2+diabetes+[abstract]+&author=RW+Bilous&author=H+Parving&author=C+Nishi&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0048"> <div class="citation-journal">Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, et al. <span class="citation-title">Effect of candesartan on prevention (DIRECT‐Prevent 1) and progression (DIRECT‐Protect 1) of retinopathy in type 1 diabetes: randomised, placebo‐controlled trials</span>. <span class="citation"> Lancet </span><span class="pubYear">2008</span>;<span class="volume">372</span>(9647):1394‐402. [MEDLINE: 18823656] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18823656" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+candesartan+on+prevention+(DIRECT%E2%80%90Prevent+1)+and+progression+(DIRECT%E2%80%90Protect+1)+of+retinopathy+in+type+1+diabetes:+randomised,+placebo%E2%80%90controlled+trials+&author=N+Chaturvedi&author=M+Porta&author=R+Klein&author=T+Orchard&author=J+Fuller&author=HH+Parving&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0049"> <div class="citation-journal">Chaturvedi N, Sjoelie AK, Svensson A, DIRECT Programme Study Group. <span class="citation-title">The DIabetic Retinopathy Candesartan Trials (DIRECT) Programme, rationale and study design</span>. <span class="citation"> Journal of the Renin‐Angiotensin‐Aldosterone System </span><span class="pubYear">2002</span>;<span class="volume">3</span>(4):255‐61. [MEDLINE: 12584669] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12584669" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+DIabetic+Retinopathy+Candesartan+Trials+(DIRECT)+Programme,+rationale+and+study+design+&author=N+Chaturvedi&author=AK+Sjoelie&author=A+Svensson&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0050"> <div class="citation-journal">Sjolie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, et al. <span class="citation-title">Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT‐Protect 2): a randomised placebo‐controlled trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2008</span>;<span class="volume">372</span>(9647):1385‐93. [MEDLINE: 18823658] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18823658" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+candesartan+on+progression+and+regression+of+retinopathy+in+type+2+diabetes+(DIRECT%E2%80%90Protect+2):+a+randomised+placebo%E2%80%90controlled+trial+&author=AK+Sjolie&author=R+Klein&author=M+Porta&author=T+Orchard&author=J+Fuller&author=HH+Parving&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0051"> <div class="citation-journal">Sjolie AK, Porta M, Parving HH, Bilous R, Klein R, DIRECT Programme Study Group. <span class="citation-title">The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics</span>. <span class="citation"> Journal of the Renin‐Angiotensin‐Aldosterone System </span><span class="pubYear">2005</span>;<span class="volume">6</span>(1):25‐32. [MEDLINE: 16088848] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16088848" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+DIabetic+REtinopathy+Candesartan+Trials+(DIRECT)+Programme:+baseline+characteristics&author=AK+Sjolie&author=M+Porta&author=HH+Parving&author=R+Bilous&author=R+Klein&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0010"> <div class="reference-title-banner"> <h4 class="title">EUCLID Study 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0052"> <div class="citation-journal">Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, et al. <span class="citation-title">Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin‐Dependent Diabetes Mellitus</span>. <span class="citation"> Lancet </span><span class="pubYear">1998</span>;<span class="volume">351</span>(9095):28‐31. [MEDLINE: 9433426] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9433426" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+lisinopril+on+progression+of+retinopathy+in+normotensive+people+with+type+1+diabetes.+The+EUCLID+Study+Group.+EURODIAB+Controlled+Trial+of+Lisinopril+in+Insulin%E2%80%90Dependent+Diabetes+Mellitus+&author=N+Chaturvedi&author=AK+Sjolie&author=JM+Stephenson&author=H+Abrahamian&author=M+Keipes&author=A+Castellarin&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0053"> <div class="citation-journal">Chaturvedi N, Stevenson J, Fuller JH, Rottiers R, Ferriss B, Karamanos B, et al. <span class="citation-title">Randomised placebo‐controlled trial of lisinopril in normotensive patients with insulin‐dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group</span>. <span class="citation"> Lancet </span><span class="pubYear">1997</span>;<span class="volume">349</span>(9068):1787‐92. [MEDLINE: 9269212] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9269212" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Randomised+placebo%E2%80%90controlled+trial+of+lisinopril+in+normotensive+patients+with+insulin%E2%80%90dependent+diabetes+and+normoalbuminuria+or+microalbuminuria.+The+EUCLID+Study+Group+&author=N+Chaturvedi&author=J+Stevenson&author=JH+Fuller&author=R+Rottiers&author=B+Ferriss&author=B+Karamanos&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0054"> <div class="citation-journal">Fuller JH, Anzalone D and EUCLID Study Group. <span class="citation-title">Renal effect of lisinopril in insulin dependent diabetes mellitus (IDDM) without hypertension [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">1996</span>;<span class="volume">7</span>(9):1357. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+effect+of+lisinopril+in+insulin+dependent+diabetes+mellitus+(IDDM)+without+hypertension+[abstract]+&author=JH+Fuller&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0055"> <div class="citation-journal">Penno G, Chaturvedi N, Talmud PJ, Cotroneo P, Manto A, Nannipieri M, et al. <span class="citation-title">Effect of angiotensin‐converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM</span>. <span class="citation"> Diabetes </span><span class="pubYear">1998</span>;<span class="volume">47</span>(9):1507‐11. [MEDLINE: 9726242] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9726242" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+angiotensin%E2%80%90converting+enzyme+(ACE)+gene+polymorphism+on+progression+of+renal+disease+and+the+influence+of+ACE+inhibition+in+IDDM+patients:+findings+from+the+EUCLID+Randomized+Controlled+Trial.+EURODIAB+Controlled+Trial+of+Lisinopril+in+IDDM+&author=G+Penno&author=N+Chaturvedi&author=PJ+Talmud&author=P+Cotroneo&author=A+Manto&author=M+Nannipieri&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0056"> <div class="citation-journal">Schalkwijk CG, Chaturvedi N, Twaafhoven H, Hinsbergh VW, Stehouwer CD, EUCLID Study Group. <span class="citation-title">Amadori‐albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients</span>. <span class="citation"> European Journal of Clinical Investigation </span><span class="pubYear">2002</span>;<span class="volume">32</span>(7):500‐6. [MEDLINE: 12153550] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12153550" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Amadori%E2%80%90albumin+correlates+with+microvascular+complications+and+precedes+nephropathy+in+type+1+diabetic+patients+&author=CG+Schalkwijk&author=N+Chaturvedi&author=H+Twaafhoven&author=VW+Hinsbergh&author=CD+Stehouwer&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0057"> <div class="citation-journal">Sjolie AK, Chaturvedi N, Fuller J. <span class="citation-title">Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin‐dependent diabetes mellitus</span>. <span class="citation"> Ugeskrift for Laeger </span><span class="pubYear">1999</span>;<span class="volume">161</span>(7):949‐52. [MEDLINE: 10051804] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10051804" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+lisinopril+on+progression+of+retinopathy+and+microalbuminuria+in+normotensive+subjects+with+insulin%E2%80%90dependent+diabetes+mellitus+&author=AK+Sjolie&author=N+Chaturvedi&author=J+Fuller&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0011"> <div class="reference-title-banner"> <h4 class="title">FACET Study 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0058"> <div class="citation-journal">Tatti P, Pahor M, Byington RP, Mauro P, Guarisco R, Strollo G, et al. <span class="citation-title">Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(4):597‐603. [MEDLINE: 9571349] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9571349" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Outcome+results+of+the+Fosinopril+Versus+Amlodipine+Cardiovascular+Events+Randomized+Trial+(FACET)+in+patients+with+hypertension+and+NIDDM+&author=P+Tatti&author=M+Pahor&author=RP+Byington&author=P+Mauro&author=R+Guarisco&author=G+Strollo&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0012"> <div class="reference-title-banner"> <h4 class="title">HOPE Study 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0059"> <div class="citation-journal">Anonymous. <span class="citation-title">The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin‐converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators</span>. <span class="citation"> Canadian Journal of Cardiology </span><span class="pubYear">1996</span>;<span class="volume">12</span>(2):127‐37. [MEDLINE: 8605634] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8605634" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+HOPE+(Heart+Outcomes+Prevention+Evaluation)+Study:+the+design+of+a+large,+simple+randomized+trial+of+an+angiotensin%E2%80%90converting+enzyme+inhibitor+(ramipril)+and+vitamin+E+in+patients+at+high+risk+of+cardiovascular+events.+The+HOPE+study+investigators+&author=+Anonymous&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0062"> <div class="citation-journal">Gerstein HC. <span class="citation-title">Diabetes and the HOPE study: implications for macrovascular and microvascular disease</span>. <span class="citation"> International Journal of Clinical Practice </span><span class="pubYear">2001</span>;<span class="volume">117</span>(Suppl):8‐12. [MEDLINE: 21572783] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Diabetes+and+the+HOPE+study:+implications+for+macrovascular+and+microvascular+disease&author=HC+Gerstein&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0060"> <div class="citation-journal">Gerstein HC, Bosch J, Pogue J, Taylor DW, Zinman B, Yusuf S. <span class="citation-title">Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high‐risk patients with diabetes. The MICRO‐HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1996</span>;<span class="volume">19</span>(11):1225‐8. [MEDLINE: 8908384] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8908384" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rationale+and+design+of+a+large+study+to+evaluate+the+renal+and+cardiovascular+effects+of+an+ACE+inhibitor+and+vitamin+E+in+high%E2%80%90risk+patients+with+diabetes.+The+MICRO%E2%80%90HOPE+Study.+Microalbuminuria,+cardiovascular,+and+renal+outcomes.+Heart+Outcomes+Prevention+Evaluation+&author=HC+Gerstein&author=J+Bosch&author=J+Pogue&author=DW+Taylor&author=B+Zinman&author=S+Yusuf&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0061"> <div class="citation-journal">Gerstein HC, Pogue J, Mann JF, Lonn E, Dagenais GR, McQueen M, et al. <span class="citation-title">The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non‐diabetic participants in the HOPE study: a prospective epidemiological analysis</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2005</span>;<span class="volume">48</span>(9):1749‐55. [MEDLINE: 16059716] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16059716" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+relationship+between+dysglycaemia+and+cardiovascular+and+renal+risk+in+diabetic+and+non%E2%80%90diabetic+participants+in+the+HOPE+study:+a+prospective+epidemiological+analysis+&author=HC+Gerstein&author=J+Pogue&author=JF+Mann&author=E+Lonn&author=GR+Dagenais&author=M+McQueen&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0063"> <div class="citation-journal">Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. <span class="citation-title">Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO‐HOPE substudy</span>. <span class="citation"> Lancet </span><span class="pubYear">2000</span>;<span class="volume">335</span>(9200):253‐9. [MEDLINE: 10675071] <ul class="citation-link-group"> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0064"> <div class="citation-journal">Hoogwerf BJ, Young JB. <span class="citation-title">The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not</span>. <span class="citation"> Cleveland Clinic Journal of Medicine </span><span class="pubYear">2000</span>;<span class="volume">67</span>(4):287‐93. [MEDLINE: 10780101] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10780101" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+HOPE+study.+Ramipril+lowered+cardiovascular+risk,+but+vitamin+E+did+not&author=BJ+Hoogwerf&author=JB+Young&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0065"> <div class="citation-journal">Lamy A, Yusuf S, Pogue J, Gafni A, Heart Outcomes Prevention Evaluation Investigators. <span class="citation-title">Cost implications of the use of ramipril in high‐risk patients based on the Heart Outcomes Prevention Evaluation (HOPE) study</span>. <span class="citation"> Circulation </span><span class="pubYear">2003</span>;<span class="volume">107</span>(7):960‐5. [MEDLINE: 12600907] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12600907" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Cost+implications+of+the+use+of+ramipril+in+high%E2%80%90risk+patients+based+on+the+Heart+Outcomes+Prevention+Evaluation+(HOPE)+study+&author=A+Lamy&author=S+Yusuf&author=J+Pogue&author=A+Gafni&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0066"> <div class="citation-journal">Lonn E, Mathew J, Pogue J, Johnstone D, Danisa K, Bosch J, et al. <span class="citation-title">Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high‐risk patients</span>. <span class="citation"> European Journal of Cardiovascular Prevention &amp; Rehabilitation </span><span class="pubYear">2003</span>;<span class="volume">10</span>(6):420‐8. [MEDLINE: 14671464] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Relationship+of+electrocardiographic+left+ventricular+hypertrophy+to+mortality+and+cardiovascular+morbidity+in+high%E2%80%90risk+patients+&author=E+Lonn&author=J+Mathew&author=J+Pogue&author=D+Johnstone&author=K+Danisa&author=J+Bosch&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0067"> <div class="citation-journal">Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, et al. <span class="citation-title">Effects of vitamin E on cardiovascular and microvascular outcomes in high‐risk patients with diabetes: results of the HOPE study and MICRO‐HOPE substudy</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2002</span>;<span class="volume">25</span>(11):1919‐27. [MEDLINE: 12401733] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12401733" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+vitamin+E+on+cardiovascular+and+microvascular+outcomes+in+high%E2%80%90risk+patients+with+diabetes:+results+of+the+HOPE+study+and+MICRO%E2%80%90HOPE+substudy+&author=E+Lonn&author=S+Yusuf&author=B+Hoogwerf&author=J+Pogue&author=Q+Yi&author=B+Zinman&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0068"> <div class="citation-journal">Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. <span class="citation-title">Renal insufficiency (RI) as predicator of cardiovascular (CV) outcomes and impact of ramipril: the HOPE study [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2000</span>;<span class="volume">11</span>(Sept):156A. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+insufficiency+(RI)+as+predicator+of+cardiovascular+(CV)+outcomes+and+impact+of+ramipril:+the+HOPE+study+[abstract]+&author=JF+Mann&author=HC+Gerstein&author=J+Pogue&author=J+Bosch&author=S+Yusuf&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0069"> <div class="citation-journal">Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. <span class="citation-title">Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">2001</span>;<span class="volume">134</span>(8):629‐36. [MEDLINE: 11304102] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11304102" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+insufficiency+as+a+predictor+of+cardiovascular+outcomes+and+the+impact+of+ramipril:+the+HOPE+randomized+trial+&author=JF+Mann&author=HC+Gerstein&author=J+Pogue&author=J+Bosch&author=S+Yusuf&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0070"> <div class="citation-journal">Mann JF, Gerstein HC, Yi QL, Franke J, Lonn EM, Hoogwerf BJ, et al. <span class="citation-title">Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study</span>. <span class="citation"> American Journal of Kidney Diseases </span><span class="pubYear">2003</span>;<span class="volume">42</span>(5):936‐42. [MEDLINE: 14582037] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14582037" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Progression+of+renal+insufficiency+in+type+2+diabetes+with+and+without+microalbuminuria:+results+of+the+Heart+Outcomes+and+Prevention+Evaluation+(HOPE)+randomized+study+&author=JF+Mann&author=HC+Gerstein&author=QL+Yi&author=J+Franke&author=EM+Lonn&author=BJ+Hoogwerf&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0071"> <div class="citation-journal">Mann JF, Gerstein HC, Yi QL, Lonn EM, Hoogwerf BJ, Rashkow A, et al. <span class="citation-title">Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2003</span>;<span class="volume">14</span>(3):641‐7. [MEDLINE: 12595499] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12595499" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Development+of+renal+disease+in+people+at+high+cardiovascular+risk:+results+of+the+HOPE+randomized+study+&author=JF+Mann&author=HC+Gerstein&author=QL+Yi&author=EM+Lonn&author=BJ+Hoogwerf&author=A+Rashkow&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0072"> <div class="citation-journal">Mann JF, Lonn EM, Yi Q, Gerstein HC, Hoogwerf BJ, Pogue J, et al. <span class="citation-title">Effects of vitamin E on cardiovascular outcomes in people with mild‐to‐moderate renal insufficiency: results of the HOPE study</span>. <span class="citation"> Kidney International </span><span class="pubYear">2004</span>;<span class="volume">65</span>(4):1375‐80. [MEDLINE: 15086477] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15086477" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+vitamin+E+on+cardiovascular+outcomes+in+people+with+mild%E2%80%90to%E2%80%90moderate+renal+insufficiency:+results+of+the+HOPE+study+&author=JF+Mann&author=EM+Lonn&author=Q+Yi&author=HC+Gerstein&author=BJ+Hoogwerf&author=J+Pogue&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0073"> <div class="citation-journal">Mann JF, Yi QL, Sleight P, Dagenais GR, Gerstein HC, Lonn EM, et al. <span class="citation-title">Serum potassium, cardiovascular risk, and effects of an ACE inhibitor: results of the HOPE study</span>. <span class="citation"> Clinical Nephrology </span><span class="pubYear">2005</span>;<span class="volume">63</span>(3):181‐7. [MEDLINE: 15786818] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15786818" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Serum+potassium,+cardiovascular+risk,+and+effects+of+an+ACE+inhibitor:+results+of+the+HOPE+study+&author=JF+Mann&author=QL+Yi&author=P+Sleight&author=GR+Dagenais&author=HC+Gerstein&author=EM+Lonn&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0074"> <div class="citation-journal">Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, et al. <span class="citation-title">Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin‐converting enzyme inhibitor ramipril</span>. <span class="citation"> Circulation </span><span class="pubYear">2001</span>;<span class="volume">104</span>(14):1615‐21. [MEDLINE: 11581138] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11581138" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Reduction+of+cardiovascular+risk+by+regression+of+electrocardiographic+markers+of+left+ventricular+hypertrophy+by+the+angiotensin%E2%80%90converting+enzyme+inhibitor+ramipril+&author=J+Mathew&author=P+Sleight&author=E+Lonn&author=D+Johnstone&author=J+Pogue&author=Q+Yi&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0075"> <div class="citation-journal">McQueen MJ, Lonn E, Gerstein HC, Bosch J, Yusuf S. <span class="citation-title">The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences</span>. <span class="citation"> Scandinavian Journal of Clinical and Laboratory Investigation Supplement </span><span class="pubYear">2005</span>;<span class="volume">240</span>:143‐56. [MEDLINE: 6112972] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16112972" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+HOPE+(Heart+Outcomes+Prevention+Evaluation)+Study+and+its+consequences&author=MJ+McQueen&author=E+Lonn&author=HC+Gerstein&author=J+Bosch&author=S+Yusuf&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0076"> <div class="citation-journal">Sleight P, Yusuf S, Pogue J, Tsuyuki R, Diaz R, Probstfield J, et al. <span class="citation-title">Blood‐pressure reduction and cardiovascular risk in HOPE study</span>. <span class="citation"> Lancet </span><span class="pubYear">2001</span>;<span class="volume">358</span>(9299):2130‐1. [MEDLINE: 11784631] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11784631" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Blood%E2%80%90pressure+reduction+and+cardiovascular+risk+in+HOPE+study&author=P+Sleight&author=S+Yusuf&author=J+Pogue&author=R+Tsuyuki&author=R+Diaz&author=J+Probstfield&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0077"> <div class="citation-journal">Smieja M, Gnarpe J, Lonn E, Gnarpe H, Olsson G, Yi Q, et al. <span class="citation-title">Multiple infections and subsequent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study</span>. <span class="citation"> Circulation </span><span class="pubYear">2003</span>;<span class="volume">107</span>(2):251‐7. [MEDLINE: 12538424] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12538424" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Multiple+infections+and+subsequent+cardiovascular+events+in+the+Heart+Outcomes+Prevention+Evaluation+(HOPE)+Study+&author=M+Smieja&author=J+Gnarpe&author=E+Lonn&author=H+Gnarpe&author=G+Olsson&author=Q+Yi&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0078"> <div class="citation-journal">Veres A, Fust G, Smieja M, McQueen M, Horvath A, Yi Q, et al. <span class="citation-title">Relationship of anti‐60 kDa heat shock protein and anti‐cholesterol antibodies to cardiovascular events</span>. <span class="citation"> Circulation </span><span class="pubYear">2002</span>;<span class="volume">106</span>(22):2775‐80. [MEDLINE: 12451002] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12451002" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Relationship+of+anti%E2%80%9060+kDa+heat+shock+protein+and+anti%E2%80%90cholesterol+antibodies+to+cardiovascular+events+&author=A+Veres&author=G+Fust&author=M+Smieja&author=M+McQueen&author=A+Horvath&author=Q+Yi&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0079"> <div class="citation-other">Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. <span class="citation-title">Effects of an angiotensin‐converting‐enzyme inhibitor, ramipril, on cardiovascular events in high‐risk patients. The Heart Outcomes Prevention Evaluation Study Investigators</span>. New England Journal of Medicine<span class="pubYear">2000</span>; Vol. 342, issue 3:145‐53. [MEDLINE: 10639539] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+an+angiotensin%E2%80%90converting%E2%80%90enzyme+inhibitor,+ramipril,+on+cardiovascular+events+in+high%E2%80%90risk+patients.+The+Heart+Outcomes+Prevention+Evaluation+Study+Investigators+&author=S+Yusuf&author=P+Sleight&author=J+Pogue&author=J+Bosch&author=R+Davies&author=G+Dagenais&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0013"> <div class="reference-title-banner"> <h4 class="title">Joglekar 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0080"> <div class="citation-journal">Joglekar SJ, Nanivadekar AS. <span class="citation-title">A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group</span>. <span class="citation"> Journal of the Association of Physicians of India </span><span class="pubYear">1998</span>;<span class="volume">Suppl 1</span>:52‐62. [MEDLINE: 11233387] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11233387" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized,+controlled,+multicenter+study+to+compare+prazosin+GITS+with+enalapril+in+hypertensive+patients+with+diabetes+mellitus.+Bombay+Hypertension+Study+Group+&author=SJ+Joglekar&author=AS+Nanivadekar&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0014"> <div class="reference-title-banner"> <h4 class="title">Kavgaci 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0081"> <div class="citation-journal">Kavgaci H, Sahin A, Onder EH, Erem C, Ozdemir F. <span class="citation-title">The effects of losartan and fosinopril in hypertensive type 2 diabetic patients</span>. <span class="citation"> Diabetes Research &amp; Clinical Practice </span><span class="pubYear">2002</span>;<span class="volume">58</span>(1):19‐25. [MEDLINE: 12161053] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+losartan+and+fosinopril+in+hypertensive+type+2+diabetic+patients&author=H+Kavgaci&author=A+Sahin&author=EH+Onder&author=C+Erem&author=F+Ozdemir&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0015"> <div class="reference-title-banner"> <h4 class="title">Kvetny 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0082"> <div class="citation-journal">Kvetny J, Gregersen G, Smith Pedersen R. <span class="citation-title">Randomized placebo‐controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus</span>. <span class="citation"> Qjm </span><span class="pubYear">2001</span>;<span class="volume">94</span>(2):89‐94. [MEDLINE: 11181984] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11181984" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Randomized+placebo%E2%80%90controlled+trial+of+perindopril+in+normotensive,+normoalbuminuric+patients+with+type+1+diabetes+mellitus+&author=J+Kvetny&author=G+Gregersen&author=R+SmithPedersen&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0016"> <div class="reference-title-banner"> <h4 class="title">Lin 1995 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0083"> <div class="citation-journal">Lin M, Yang YF, Chiang HT, Lee D, Wang SP, Chang MS, et al. <span class="citation-title">Beneficial effects of angiotensin‐converting enzyme inhibitors on cardiovascular and renal functions in patients with hypertension and diabetes</span>. <span class="citation"> Acta Cardiologica Sinica </span><span class="pubYear">1995</span>;<span class="volume">11</span>(1):30‐8. [EMBASE: 1995122137] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Beneficial+effects+of+angiotensin%E2%80%90converting+enzyme+inhibitors+on+cardiovascular+and+renal+functions+in+patients+with+hypertension+and+diabetes+&author=M+Lin&author=YF+Yang&author=HT+Chiang&author=D+Lee&author=SP+Wang&author=MS+Chang&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0017"> <div class="reference-title-banner"> <h4 class="title">ONTARGET Study 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0084"> <div class="citation-journal">Barzilay JI, Gao P, O'Donnell M, Mann JF, Anderson C, Fagard R, et al. <span class="citation-title">Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">2011</span>;<span class="volume">171</span>(2):142‐50. [MEDLINE: 21263104] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21263104" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Albuminuria+and+decline+in+cognitive+function:+The+ONTARGET/TRANSCEND+studies&author=JI+Barzilay&author=P+Gao&author=M+O'Donnell&author=JF+Mann&author=C+Anderson&author=R+Fagard&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0085"> <div class="citation-journal">Cukierman‐Yaffe T, Gerstein HC, Anderson C, Zhao F, Sleight P, Hilbrich L, et al. <span class="citation-title">Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme</span>. <span class="citation"> Diabetes Research &amp; Clinical Practice </span><span class="pubYear">2009 Mar</span>;<span class="volume">83</span>(3):387‐93. [MEDLINE: 19157618] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glucose+intolerance+and+diabetes+as+risk+factors+for+cognitive+impairment+in+people+at+high+cardiovascular+risk:+results+from+the+ONTARGET/TRANSCEND+research+programme+&author=T+Cukierman%E2%80%90Yaffe&author=HC+Gerstein&author=C+Anderson&author=F+Zhao&author=P+Sleight&author=L+Hilbrich&publication_year=2009Mar&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0086"> <div class="citation-journal">Gallieni M, Cozzolino M, Brancaccio D, Giovannini M. <span class="citation-title">Renal outcomes in the ONTARGET study</span>. <span class="citation"> Lancet </span><span class="pubYear">2008</span>;<span class="volume">372</span>(9655):2019‐21. [MEDLINE: 19070732] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19070732" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+outcomes+in+the+ONTARGET+study&author=M+Gallieni&author=M+Cozzolino&author=D+Brancaccio&author=M+Giovannini&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0087"> <div class="citation-journal">Mancia G, Schumacher H, Redon J, Verdecchia P, Schmieder R, Jennings G, et al. <span class="citation-title">Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)</span>. <span class="citation"> Circulation </span><span class="pubYear">2011</span>;<span class="volume">124</span>(16):1727‐36. [MEDLINE: 21947289] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21947289" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Blood+pressure+targets+recommended+by+guidelines+and+incidence+of+cardiovascular+and+renal+events+in+the+Ongoing+Telmisartan+Alone+and+in+Combination+With+Ramipril+Global+Endpoint+Trial+(ONTARGET)+&author=G+Mancia&author=H+Schumacher&author=J+Redon&author=P+Verdecchia&author=R+Schmieder&author=G+Jennings&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0088"> <div class="citation-journal">Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, et al. <span class="citation-title">Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double‐blind, controlled trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2008</span>;<span class="volume">372</span>(9638):547‐53. [MEDLINE: 18707986] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18707986" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+outcomes+with+telmisartan,+ramipril,+or+both,+in+people+at+high+vascular+risk+(the+ONTARGET+study):+a+multicentre,+randomised,+double%E2%80%90blind,+controlled+trial+&author=JF+Mann&author=RE+Schmieder&author=M+McQueen&author=L+Dyal&author=H+Schumacher&author=J+Pogue&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0089"> <div class="citation-journal">Mann JF, Schmieder RE, McQueen MM, Dyal L, Schumacher H, Pogue J, et al. <span class="citation-title">Renal outcomes with telmisartan, ramipril, or both in people at high vascular risk: results from the ONTARGET trial [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2008</span>;<span class="volume">17</span>(Abstracts Issue):48A. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+outcomes+with+telmisartan,+ramipril,+or+both+in+people+at+high+vascular+risk:+results+from+the+ONTARGET+trial+[abstract]+&author=JF+Mann&author=RE+Schmieder&author=MM+McQueen&author=L+Dyal&author=H+Schumacher&author=J+Pogue&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0090"> <div class="citation-journal">Mann JF, Schmieder RE, McQueen MM, Dyal L, Schumacher H, Pogue J, et al. <span class="citation-title">Renal outcomes with telmisartan, ramipril, or both in people at high vascular risk: results from the ONTARGET trial [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2008</span>;<span class="volume">19</span>(Abstracts Issue):48A. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+outcomes+with+telmisartan,+ramipril,+or+both+in+people+at+high+vascular+risk:+results+from+the+ONTARGET+trial+[abstract]+&author=JF+Mann&author=RE+Schmieder&author=MM+McQueen&author=L+Dyal&author=H+Schumacher&author=J+Pogue&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0091"> <div class="citation-journal">Narayanan RM, Chi LS, Choo LL, Ying YL, Fang SC. <span class="citation-title">Renal outcomes in the ONTARGET study</span>. <span class="citation"> Lancet </span><span class="pubYear">2008</span>;<span class="volume">372</span>(9655):2020‐1. [MEDLINE: 19070735] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19070735" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+outcomes+in+the+ONTARGET+study&author=RM+Narayanan&author=LS+Chi&author=LL+Choo&author=YL+Ying&author=SC+Fang&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0092"> <div class="citation-journal">Nonoguchi H, Nanami M, Hasuike Y, Kuragano T, Nakanishi T. <span class="citation-title">Renal outcomes in the ONTARGET study</span>. <span class="citation"> Lancet </span><span class="pubYear">2008</span>;<span class="volume">372</span>(9655):2019‐20. [MEDLINE: 19070731] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19070731" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+outcomes+in+the+ONTARGET+study&author=H+Nonoguchi&author=M+Nanami&author=Y+Hasuike&author=T+Kuragano&author=T+Nakanishi&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0093"> <div class="citation-journal">ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, et al. <span class="citation-title">Telmisartan, ramipril, or both in patients at high risk for vascular events</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2008</span>;<span class="volume">358</span>(15):1547‐59. [MEDLINE: 8378520] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18378520" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Telmisartan,+ramipril,+or+both+in+patients+at+high+risk+for+vascular+events&author=S+Yusuf&author=KK+Teo&author=J+Pogue&author=L+Dyal&author=I+Copland&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0094"> <div class="citation-journal">Ruilope LM, Redon J, Schmieder R. <span class="citation-title">Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme</span>. <span class="citation"> Vascular Health &amp; Risk Management </span><span class="pubYear">2007</span>;<span class="volume">3</span>(1):1‐9. [MEDLINE: 17583170] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Cardiovascular+risk+reduction+by+reversing+endothelial+dysfunction:+ARBs,+ACE+inhibitors,+or+both?+Expectations+from+the+ONTARGET+Trial+Programme+&author=LM+Ruilope&author=J+Redon&author=R+Schmieder&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0095"> <div class="citation-journal">Schmieder RE, Mann JFE, Dyal L, Pogue J, Copland I, Teo KK, et al. <span class="citation-title">ONTARGET: cardiovascular outcome in patients at high cardiovascular risk and with chronic kidney disease (CKD) [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2008</span>;<span class="volume">19</span>(Abstracts Issue):309A. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=ONTARGET:+cardiovascular+outcome+in+patients+at+high+cardiovascular+risk+and+with+chronic+kidney+disease+(CKD)+[abstract]+&author=RE+Schmieder&author=JFE+Mann&author=L+Dyal&author=J+Pogue&author=I+Copland&author=KK+Teo&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0097"> <div class="citation-journal">Sleight P. <span class="citation-title">Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin‐converting enzyme inhibitor</span>. <span class="citation"> Journal of Hypertension ‐ Supplement </span><span class="pubYear">2009</span>;<span class="volume">27</span>(Suppl 5):S23‐9. [MEDLINE: 19587551] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Clinical+evidence+from+ONTARGET:+the+value+of+an+angiotensin+II+receptor+blocker+and+an+angiotensin%E2%80%90converting+enzyme+inhibitor+&author=P+Sleight&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0096"> <div class="citation-journal">Sleight P, Redon J, Verdecchia P, Mancia G, Gao P, Fagard R, et al. <span class="citation-title">Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study</span>. <span class="citation"> Journal of Hypertension </span><span class="pubYear">2009</span>;<span class="volume">27</span>(7):1360‐9. [MEDLINE: 19506526] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19506526" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prognostic+value+of+blood+pressure+in+patients+with+high+vascular+risk+in+the+Ongoing+Telmisartan+Alone+and+in+combination+with+Ramipril+Global+Endpoint+Trial+study+&author=P+Sleight&author=J+Redon&author=P+Verdecchia&author=G+Mancia&author=P+Gao&author=R+Fagard&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0098"> <div class="citation-journal">Teo K, Yusuf S, Sleight P, Anderson C, Mookadam F, Ramos B, et al. <span class="citation-title">Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high‐risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials</span>. <span class="citation"> American Heart Journal </span><span class="pubYear">2004</span>;<span class="volume">148</span>(1):52‐61. [MEDLINE: 15215792] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15215792" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rationale,+design,+and+baseline+characteristics+of+2+large,+simple,+randomized+trials+evaluating+telmisartan,+ramipril,+and+their+combination+in+high%E2%80%90risk+patients:+the+Ongoing+Telmisartan+Alone+and+in+Combination+with+Ramipril+Global+Endpoint+Trial/Telmisartan+Randomized+Assessment+Study+in+ACE+Intolerant+Subjects+with+Cardiovascular+Disease+(ONTARGET/TRANSCEND)+trials+&author=K+Teo&author=S+Yusuf&author=P+Sleight&author=C+Anderson&author=F+Mookadam&author=B+Ramos&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0099"> <div class="citation-journal">Wetzels JF. <span class="citation-title">Renal outcomes in the ONTARGET study</span>. <span class="citation"> Lancet </span><span class="pubYear">2008</span>;<span class="volume">372</span>(9655):2020‐1. [MEDLINE: 19070734] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19070734" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+outcomes+in+the+ONTARGET+study&author=JF+Wetzels&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0018"> <div class="reference-title-banner"> <h4 class="title">Perrin 2008 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0100"> <div class="citation-journal">Perrin NE, Jaremko GA, Berg UB. <span class="citation-title">The effect of candesartan/placebo treatment on renal function and morphology in diabetes type 1 [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2007</span>;<span class="volume">18</span>(Abstracts):327A. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effect+of+candesartan/placebo+treatment+on+renal+function+and+morphology+in+diabetes+type+1+[abstract]+&author=NE+Perrin&author=GA+Jaremko&author=UB+Berg&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0101"> <div class="citation-journal">Perrin NE, Jaremko GA, Berg UB. <span class="citation-title">The effects of candesartan on diabetes glomerulopathy: a double‐blind, placebo‐controlled trial</span>. <span class="citation"> Pediatric Nephrology </span><span class="pubYear">2008</span>;<span class="volume">23</span>(6):947‐54. [MEDLINE: 18270751] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18270751" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+effects+of+candesartan+on+diabetes+glomerulopathy:+a+double%E2%80%90blind,+placebo%E2%80%90controlled+trial+&author=NE+Perrin&author=GA+Jaremko&author=UB+Berg&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0019"> <div class="reference-title-banner"> <h4 class="title">RASS Study 2002 {published and unpublished data} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0102"> <div class="citation-journal">Donnelly S, Goodyear P, Ly J, Klein R, Moss S, Sinsiko A, et al. <span class="citation-title">Renal biopsy complications in the RASS study [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2005</span>;<span class="volume">16</span>:559A. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+biopsy+complications+in+the+RASS+study+[abstract]&author=S+Donnelly&author=P+Goodyear&author=J+Ly&author=R+Klein&author=S+Moss&author=A+Sinsiko&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0103"> <div class="citation-journal">Donnelly S, Sinaiko A, Strand T, Zinman B, Drummond K, Gardiner R, et al. <span class="citation-title">Effects of renin angiotensin system (RAS) blockade on diabetic nephropathy (DN)‐a primary prevention trial: study design and baseline results [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2002</span>;<span class="volume">13</span>(Program &amp; Abstracts):651A. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+renin+angiotensin+system+(RAS)+blockade+on+diabetic+nephropathy+(DN)%E2%80%90a+primary+prevention+trial:+study+design+and+baseline+results+[abstract]+&author=S+Donnelly&author=A+Sinaiko&author=T+Strand&author=B+Zinman&author=K+Drummond&author=R+Gardiner&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0104"> <div class="citation-journal">Katavetin P, Katavetin P. <span class="citation-title">Renal and retinal effects of enalapril and losartan in type 1 diabetes</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2009</span>;<span class="volume">361</span>(14):1410‐1. [MEDLINE: 19802919] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19802919" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+and+retinal+effects+of+enalapril+and+losartan+in+type+1+diabetes&author=P+Katavetin&author=P+Katavetin&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0105"> <div class="citation-journal">Mauer M, Strand T, Zinman B, Gardiner R, Suissa S, Sinaiko A, et al. <span class="citation-title">The Renin Angiotensin System Study (RASS): compliance in a long‐term kidney biopsy based diabetic nephropathy (DN) primary prevention trial in Type 1 diabetes mellitus (T1DM) patients (pts) [abstract]</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2005</span>;<span class="volume">16</span>:554A. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+Renin+Angiotensin+System+Study+(RASS):+compliance+in+a+long%E2%80%90term+kidney+biopsy+based+diabetic+nephropathy+(DN)+primary+prevention+trial+in+Type+1+diabetes+mellitus+(T1DM)+patients+(pts)+[abstract]+&author=M+Mauer&author=T+Strand&author=B+Zinman&author=R+Gardiner&author=S+Suissa&author=A+Sinaiko&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0106"> <div class="citation-journal">Mauer M, Zinman B, Gardiner R, Drummond KN, Suissa S, Donnelly SM, et al. <span class="citation-title">ACE‐I and ARBs in early diabetic nephropathy</span>. <span class="citation"> Journal of the Renin‐Angiotensin‐Aldosterone System </span><span class="pubYear">2002</span>;<span class="volume">3</span>(4):262‐9. [MEDLINE: 12584670] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12584670" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=ACE%E2%80%90I+and+ARBs+in+early+diabetic+nephropathy&author=M+Mauer&author=B+Zinman&author=R+Gardiner&author=KN+Drummond&author=S+Suissa&author=SM+Donnelly&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0107"> <div class="citation-journal">Mauer M, Zinman B, Gardiner R, Suissa S, Sinaiko A, Strand T, et al. <span class="citation-title">Renal and retinal effects of enalapril and losartan in type 1 diabetes</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2009</span>;<span class="volume">361</span>(1):40‐51. [MEDLINE: 19571282] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19571282" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+and+retinal+effects+of+enalapril+and+losartan+in+type+1+diabetes&author=M+Mauer&author=B+Zinman&author=R+Gardiner&author=S+Suissa&author=A+Sinaiko&author=T+Strand&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0108"> <div class="citation-journal">Robiner WN, Yozwiak JA, Bearman DL, Strand TD, Strasburg KR. <span class="citation-title">Barriers to clinical research participation in a diabetes randomized clinical trial</span>. <span class="citation"> Social Science &amp; Medicine </span><span class="pubYear">2009</span>;<span class="volume">68</span>(6):1069‐74. [MEDLINE: 19167143] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Barriers+to+clinical+research+participation+in+a+diabetes+randomized+clinical+trial&author=WN+Robiner&author=JA+Yozwiak&author=DL+Bearman&author=TD+Strand&author=KR+Strasburg&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0109"> <div class="citation-other">Suissa S. <span class="citation-title">Renin angiotensin system study (RASS) of diabetic nephropathy</span>. (study protocol). <ul class="citation-link-group"> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0110"> <div class="citation-journal">Tamsma JT. <span class="citation-title">Renal and retinal effects of enalapril and losartan in type 1 diabetes</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2009</span>;<span class="volume">361</span>(14):1410. [MEDLINE: 19797291] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19797291" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Renal+and+retinal+effects+of+enalapril+and+losartan+in+type+1+diabetes&author=JT+Tamsma&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0020"> <div class="reference-title-banner"> <h4 class="title">Ravid 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0111"> <div class="citation-journal">Ravid M, Brosh D, Levi Z, Bar‐Dayan Y, Ravid D, Rachmani R. <span class="citation-title">Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus: a randomized, controlled trial</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">1998</span>;<span class="volume">128</span>(12 Pt 1):982‐8. [MEDLINE: 9625684] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9625684" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Use+of+enalapril+to+attenuate+decline+in+renal+function+in+normotensive,+normoalbuminuric+patients+with+type+2+diabetes+mellitus:+a+randomized,+controlled+trial+&author=M+Ravid&author=D+Brosh&author=Z+Levi&author=Y+Bar%E2%80%90Dayan&author=D+Ravid&author=R+Rachmani&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0021"> <div class="reference-title-banner"> <h4 class="title">ROADMAP Study 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0112"> <div class="citation-journal">Haller H, Ito S, Izzo JL, Januszewicz A, Katayama S, Menne J, et al. <span class="citation-title">Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">2011</span>;<span class="volume">364</span>(10):907‐17. [MEDLINE: 21388309] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21388309" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Olmesartan+for+the+delay+or+prevention+of+microalbuminuria+in+type+2+diabetes&author=H+Haller&author=S+Ito&author=JL+Izzo&author=A+Januszewicz&author=S+Katayama&author=J+Menne&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0113"> <div class="citation-journal">Haller H, Viberti GC, Mimran A, Remuzzi G, Rabelink AJ, Ritz E, et al. <span class="citation-title">Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study</span>. <span class="citation"> Journal of Hypertension </span><span class="pubYear">2006</span>;<span class="volume">24</span>(2):403‐8. [MEDLINE: 16508590] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16508590" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Preventing+microalbuminuria+in+patients+with+diabetes:+rationale+and+design+of+the+Randomised+Olmesartan+and+Diabetes+Microalbuminuria+Prevention+(ROADMAP)+study+&author=H+Haller&author=GC+Viberti&author=A+Mimran&author=G+Remuzzi&author=AJ+Rabelink&author=E+Ritz&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0114"> <div class="citation-other">Haller HG, Viberti GV, Ritz E, Ruilope LM, Rabelink TJ, for the ROADMAP Steering Committee Members. <span class="citation-title">Prevention of albuminuria and cardiovascular morbidity with olmesartan, the ROADMAP trial</span>. ASN Renal Week. <span class="pubYear">2009</span>:LB‐005. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prevention+of+albuminuria+and+cardiovascular+morbidity+with+olmesartan,+the+ROADMAP+trial+&author=HG+Haller&author=GV+Viberti&author=E+Ritz&author=LM+Ruilope&author=TJ+Rabelink&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0115"> <div class="citation-journal">Januszewicz A, Ritz E, Viberti G, Mimran A, Rabelink AJ, Rump LC, et al. <span class="citation-title">Office and ambulatory pulse pressure‐‐association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study)</span>. <span class="citation"> Journal of Human Hypertension </span><span class="pubYear">2011</span>;<span class="volume">25</span>(11):679‐85. [MEDLINE: 21150933] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21150933" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Office+and+ambulatory+pulse+pressure%E2%80%90%E2%80%90association+with+clinical+characteristics+and+cardiovascular+risk+factors+in+normoalbuminuric+patients+with+type+2+diabetes+(ROADMAP+study)+&author=A+Januszewicz&author=E+Ritz&author=G+Viberti&author=A+Mimran&author=AJ+Rabelink&author=LC+Rump&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0116"> <div class="citation-journal">Menne J, Izzo JL, Ito S, Januszewicz A, Katayama S, Chatzykirkou C, et al. <span class="citation-title">Prevention of microalbuminuria in patients with type 2 diabetes and hypertension</span>. <span class="citation"> Journal of Hypertension </span><span class="pubYear">2012</span>;<span class="volume">30</span>(4):811‐8. [MEDLINE: 22418908] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/22418908" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prevention+of+microalbuminuria+in+patients+with+type+2+diabetes+and+hypertension&author=J+Menne&author=JL+Izzo&author=S+Ito&author=A+Januszewicz&author=S+Katayama&author=C+Chatzykirkou&publication_year=2012&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0117"> <div class="citation-journal">Ritz E, Viberti GC, Ruilope LM, Rabelink AJ, Izzo JL, Katayama S, et al. <span class="citation-title">Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2010</span>;<span class="volume">53</span>(1):49‐57. [MEDLINE: 19876613] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19876613" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Determinants+of+urinary+albumin+excretion+within+the+normal+range+in+patients+with+type+2+diabetes:+the+Randomised+Olmesartan+and+Diabetes+Microalbuminuria+Prevention+(ROADMAP)+study+&author=E+Ritz&author=GC+Viberti&author=LM+Ruilope&author=AJ+Rabelink&author=JL+Izzo&author=S+Katayama&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0022"> <div class="reference-title-banner"> <h4 class="title">Scognamiglio 1997 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0118"> <div class="citation-journal">Scognamiglio R, Nosadini R, Marin M, Nisti S, Fasoli G, Palisi M, et al. <span class="citation-title">Evaluation of the efficacy and tolerability of nitrendipine in reducing both pressure and left ventricular mass in hypertensive type 2 diabetic patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20</span>(8):1290‐2. [MEDLINE: 9250456] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9250456" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Evaluation+of+the+efficacy+and+tolerability+of+nitrendipine+in+reducing+both+pressure+and+left+ventricular+mass+in+hypertensive+type+2+diabetic+patients+&author=R+Scognamiglio&author=R+Nosadini&author=M+Marin&author=S+Nisti&author=G+Fasoli&author=M+Palisi&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0023"> <div class="reference-title-banner"> <h4 class="title">TRANSCEND Study 2009 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0119"> <div class="citation-journal">Barzilay JI, Gao P, O'Donnell M, Mann JF, Anderson C, Fagard R, et al. <span class="citation-title">Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies</span>. <span class="citation"> Archives of Internal Medicine </span><span class="pubYear">2011</span>;<span class="volume">171</span>(2):142‐50. [MEDLINE: 21263104] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/21263104" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Albuminuria+and+decline+in+cognitive+function:+The+ONTARGET/TRANSCEND+studies&author=JI+Barzilay&author=P+Gao&author=M+O'Donnell&author=JF+Mann&author=C+Anderson&author=R+Fagard&publication_year=2011&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0120"> <div class="citation-journal">Cukierman‐Yaffe T, Gerstein HC, Anderson C, Zhao F, Sleight P, Hilbrich L, et al. <span class="citation-title">Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme</span>. <span class="citation"> Diabetes Research &amp; Clinical Practice </span><span class="pubYear">2009</span>;<span class="volume">83</span>(3):387‐93. [MEDLINE: 19157618] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glucose+intolerance+and+diabetes+as+risk+factors+for+cognitive+impairment+in+people+at+high+cardiovascular+risk:+results+from+the+ONTARGET/TRANSCEND+research+programme+&author=T+Cukierman%E2%80%90Yaffe&author=HC+Gerstein&author=C+Anderson&author=F+Zhao&author=P+Sleight&author=L+Hilbrich&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0121"> <div class="citation-journal">Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, et al. <span class="citation-title">Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk</span>. <span class="citation"> Circulation </span><span class="pubYear">2007</span>;<span class="volume">115</span>(11):1371‐5. [MEDLINE: 17339550] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17339550" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glucose+levels+predict+hospitalization+for+congestive+heart+failure+in+patients+at+high+cardiovascular+risk+&author=C+Held&author=HC+Gerstein&author=S+Yusuf&author=F+Zhao&author=L+Hilbrich&author=C+Anderson&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0122"> <div class="citation-journal">Mann JF, Schmieder RE, Dyal L, McQueen MJ, Schumacher H, Pogue J, et al. <span class="citation-title">Effect of telmisartan on renal outcomes: a randomized trial</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">2009</span>;<span class="volume">151</span>(1):1‐10. [MEDLINE: 19451556] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19451556" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+telmisartan+on+renal+outcomes:+a+randomized+trial&author=JF+Mann&author=RE+Schmieder&author=L+Dyal&author=MJ+McQueen&author=H+Schumacher&author=J+Pogue&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0123"> <div class="citation-journal">Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators. Yusuf S. Teo K. Anderson C. Pogue J. Dyal L, et al. <span class="citation-title">Effects of the angiotensin‐receptor blocker telmisartan on cardiovascular events in high‐risk patients intolerant to angiotensin‐converting enzyme inhibitors: a randomised controlled trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2008</span>;<span class="volume">372</span>(9644):1174‐83. [MEDLINE: 18757085] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18757085" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0124"> <div class="citation-journal">Teo K, Yusuf S, Sleight P, Anderson C, Mookadam F, Ramos B, et al. <span class="citation-title">Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high‐risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials</span>. <span class="citation"> American Heart Journal </span><span class="pubYear">2004</span>;<span class="volume">148</span>(1):52‐61. [MEDLINE: 15215792] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15215792" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Rationale,+design,+and+baseline+characteristics+of+2+large,+simple,+randomized+trials+evaluating+telmisartan,+ramipril,+and+their+combination+in+high%E2%80%90risk+patients:+the+Ongoing+Telmisartan+Alone+and+in+Combination+with+Ramipril+Global+Endpoint+Trial/Telmisartan+Randomized+Assessment+Study+in+ACE+Intolerant+Subjects+with+Cardiovascular+Disease+(ONTARGET/TRANSCEND)+trials+&author=K+Teo&author=S+Yusuf&author=P+Sleight&author=C+Anderson&author=F+Mookadam&author=B+Ramos&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0024"> <div class="reference-title-banner"> <h4 class="title">Tuominen 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0125"> <div class="citation-journal">Tuominen JA, Ebeling P, Koivisto VA. <span class="citation-title">Long‐term lisinopril therapy reduces exercise‐induced albuminuria in normoalbuminuric normotensive IDDM patients</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1998</span>;<span class="volume">21</span>(8):1345‐8. [MEDLINE: 9702445] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9702445" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90term+lisinopril+therapy+reduces+exercise%E2%80%90induced+albuminuria+in+normoalbuminuric+normotensive+IDDM+patients+&author=JA+Tuominen&author=P+Ebeling&author=VA+Koivisto&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0025"> <div class="reference-title-banner"> <h4 class="title">UKPDS Study 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0126"> <div class="citation-journal">Anonymous. <span class="citation-title">UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1991</span>;<span class="volume">34</span>(12):877‐90. [MEDLINE: 1778353] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1778353" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=UK+Prospective+Diabetes+Study+(UKPDS).+VIII.+Study+design,+progress+and+performance&author=+Anonymous&publication_year=1991&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0127"> <div class="citation-journal">Holman R, Turner R, Stratton I, Cull C, Frighi V, Manley S, et al. <span class="citation-title">Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group</span>. <span class="citation"> BMJ </span><span class="pubYear">1998</span>;<span class="volume">317</span>(7160):713‐20. [MEDLINE: 9732338] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9732338" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+atenolol+and+captopril+in+reducing+risk+of+macrovascular+and+microvascular+complications+in+type+2+diabetes:+UKPDS+39.+UK+Prospective+Diabetes+Study+Group+&author=R+Holman&author=R+Turner&author=I+Stratton&author=C+Cull&author=V+Frighi&author=S+Manley&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0128"> <div class="citation-journal">UK PDS Group. <span class="citation-title">Intensive blood‐glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group</span>. <span class="citation"> Lancet </span><span class="pubYear">1998</span>;<span class="volume">352</span>(9131):837‐53. [MEDLINE: 9742976] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9742976" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0129"> <div class="citation-journal">UK PDS Group. <span class="citation-title">Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group</span>. <span class="citation"> BMJ </span><span class="pubYear">1998</span>;<span class="volume">317</span>(7160):703‐13. [MEDLINE: 9732337] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9732337" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD004136-bbs2-0026"> <div class="reference-title-banner"> <h4 class="title">Velussi 1996 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0130"> <div class="citation-journal">Velussi M, Brocco E, Frigato F, Zolli M, Muollo B, Maioli M, et al. <span class="citation-title">Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients</span>. <span class="citation"> Diabetes </span><span class="pubYear">1996</span>;<span class="volume">45</span>(2):216‐22. [MEDLINE: 8549868] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8549868" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+cilazapril+and+amlodipine+on+kidney+function+in+hypertensive+NIDDM+patients&author=M+Velussi&author=E+Brocco&author=F+Frigato&author=M+Zolli&author=B+Muollo&author=M+Maioli&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD004136-bbs1-0002"> <h3 class="title">References to studies excluded from this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD004136-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD004136-bbs1-0003">additional references</a></li> <li><a class="jump-to" href="#CD004136-bbs1-0004">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_excludedStudies" id="CD004136-bbs2-0027"> <div class="reference-title-banner"> <h4 class="title">ALLHAT 2002 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0131"> <div class="citation-journal">ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial. <span class="citation-title">Major outcomes in high‐risk hypertensive patients randomized to angiotensin‐converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)</span>. <span class="citation"> JAMA </span><span class="pubYear">2002</span>;<span class="volume">288</span>(23):2981‐97. [MEDLINE: 12479763] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12479763" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> <div class="bibliography-section" id="CD004136-bib-0132"> <div class="citation-journal">Messerli HF. <span class="citation-title">Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2000</span>;<span class="volume">355</span>(9207):863‐4. [MEDLINE: 10752699] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10752699" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Implications+of+discontinuation+of+doxazosin+arm+of+ALLHAT.+Antihypertensive+and+Lipid%E2%80%90Lowering+Treatment+to+Prevent+Heart+Attack+Trial+&author=HF+Messerli&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD004136-bbs2-0028"> <div class="reference-title-banner"> <h4 class="title">CAPPP 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0133"> <div class="citation-journal">Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, et al. <span class="citation-title">Effect of angiotensin‐converting‐enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial</span>. <span class="citation"> Lancet </span><span class="pubYear">1999</span>;<span class="volume">353</span>(9153):611‐6. [MEDLINE: 10030325] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10030325" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+angiotensin%E2%80%90converting%E2%80%90enzyme+inhibition+compared+with+conventional+therapy+on+cardiovascular+morbidity+and+mortality+in+hypertension:+the+Captopril+Prevention+Project+(CAPPP)+randomised+trial+&author=L+Hansson&author=LH+Lindholm&author=L+Niskanen&author=J+Lanke&author=T+Hedner&author=A+Niklason&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD004136-bbs2-0029"> <div class="reference-title-banner"> <h4 class="title">Hansson 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0134"> <div class="citation-journal">Hansson L, Lindholm LH, Ekbom T, Dahlof B, Lanke J, Schersten B, et al. <span class="citation-title">Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension‐2 study</span>. <span class="citation"> Lancet </span><span class="pubYear">1999</span>;<span class="volume">354</span>(9192):1751‐6. [MEDLINE: 10577635] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10577635" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Randomised+trial+of+old+and+new+antihypertensive+drugs+in+elderly+patients:+cardiovascular+mortality+and+morbidity+the+Swedish+Trial+in+Old+Patients+with+Hypertension%E2%80%902+study+&author=L+Hansson&author=LH+Lindholm&author=T+Ekbom&author=B+Dahlof&author=J+Lanke&author=B+Schersten&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD004136-bbs2-0030"> <div class="reference-title-banner"> <h4 class="title">HOT 1998 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0135"> <div class="citation-journal">Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. <span class="citation-title">Effects of intensive blood‐pressure lowering and low‐dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial</span>. <span class="citation"> Lancet </span><span class="pubYear">1998</span>;<span class="volume">351</span>(9118):1755‐62. [MEDLINE: 9635947] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9635947" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+intensive+blood%E2%80%90pressure+lowering+and+low%E2%80%90dose+aspirin+in+patients+with+hypertension:+principal+results+of+the+Hypertension+Optimal+Treatment+(HOT)+randomised+trial+&author=L+Hansson&author=A+Zanchetti&author=SG+Carruthers&author=B+Dahlof&author=D+Elmfeldt&author=S+Julius&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD004136-bbs2-0031"> <div class="reference-title-banner"> <h4 class="title">INSIGHT 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0136"> <div class="citation-journal">Brown MJ, Palmer CR, Castaigne A, Leeuw PW, Mancia G, Rosenthal T, et al. <span class="citation-title">Morbidity and mortality in patients randomised to double‐blind treatment with a long‐acting calcium‐channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)</span>. <span class="citation"> Lancet </span><span class="pubYear">2000</span>;<span class="volume">356</span>(9227):366‐72. [MEDLINE: 10972368] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10972368" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Morbidity+and+mortality+in+patients+randomised+to+double%E2%80%90blind+treatment+with+a+long%E2%80%90acting+calcium%E2%80%90channel+blocker+or+diuretic+in+the+International+Nifedipine+GITS+study:+Intervention+as+a+Goal+in+Hypertension+Treatment+(INSIGHT)+&author=MJ+Brown&author=CR+Palmer&author=A+Castaigne&author=PW+Leeuw&author=G+Mancia&author=T+Rosenthal&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD004136-bbs2-0032"> <div class="reference-title-banner"> <h4 class="title">NORDIL 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0137"> <div class="citation-journal">Hansson L, Hedner T, Lund‐Johansen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, et al. <span class="citation-title">Randomised trial of effects of calcium antagonists compared with diuretics and beta‐blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study</span>. <span class="citation"> Lancet </span><span class="pubYear">2000</span>;<span class="volume">356</span>(9227):359‐65. [MEDLINE: 10972367] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10972367" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Randomised+trial+of+effects+of+calcium+antagonists+compared+with+diuretics+and+beta%E2%80%90blockers+on+cardiovascular+morbidity+and+mortality+in+hypertension:+the+Nordic+Diltiazem+(NORDIL)+study+&author=L+Hansson&author=T+Hedner&author=P+Lund%E2%80%90Johansen&author=SE+Kjeldsen&author=LH+Lindholm&author=JO+Syvertsen&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD004136-bbs2-0033"> <div class="reference-title-banner"> <h4 class="title">Tuomilehto 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD004136-bib-0138"> <div class="citation-journal">Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, et al. <span class="citation-title">Effects of calcium‐channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1999</span>;<span class="volume">340</span>(9):677‐84. [MEDLINE: 10053176] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10053176" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+calcium%E2%80%90channel+blockade+in+older+patients+with+diabetes+and+systolic+hypertension.+Systolic+Hypertension+in+Europe+Trial+Investigators+&author=J+Tuomilehto&author=D+Rastenyte&author=WH+Birkenhager&author=L+Thijs&author=R+Antikainen&author=CJ+Bulpitt&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD004136-bbs1-0003"> <h3 class="title">Additional references</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD004136-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD004136-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD004136-bbs1-0004">other published versions</a></li> </ul> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0034"> <div class="reference-title-banner"> <h4 class="title">ADA 2010</h4> </div> <div class="bibliography-section" id="CD004136-bib-0139"> <div class="citation-journal">American Diabetes Association. <span class="citation-title">Standards of Medical Care in Diabetes—2010</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2010</span>;<span class="volume">33</span>(Suppl 1):S11‐61. [MEDLINE: 14693929] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20042772" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0035"> <div class="reference-title-banner"> <h4 class="title">Adler 2003</h4> </div> <div class="bibliography-section" id="CD004136-bib-0140"> <div class="citation-journal">Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. <span class="citation-title">Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)</span>. <span class="citation"> Kidney International </span><span class="pubYear">2003</span>;<span class="volume">63</span>(1):225‐32. [MEDLINE: 12472787] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12472787" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Development+and+progression+of+nephropathy+in+type+2+diabetes:+The+United+Kingdom+Prospective+Diabetes+Study+(UKPDS+64)+&author=AI+Adler&author=RJ+Stevens&author=SE+Manley&author=RW+Bilous&author=CA+Cull&author=RR+Holman&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0036"> <div class="reference-title-banner"> <h4 class="title">Bucher 1997</h4> </div> <div class="bibliography-section" id="CD004136-bib-0141"> <div class="citation-journal">Bucher HC, Guyatt GH, Griffith LE, Walter SD. <span class="citation-title">The results of direct and indirect treatment comparisons in meta‐analysis of randomized controlled trials</span>. <span class="citation"> Journal of Clinical Epidemiology </span><span class="pubYear">1997</span>;<span class="volume">50</span>(6):683‐91. [MEDLINE: 9250266] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9250266" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+results+of+direct+and+indirect+treatment+comparisons+in+meta%E2%80%90analysis+of+randomized+controlled+trials+&author=HC+Bucher&author=GH+Guyatt&author=LE+Griffith&author=SD+Walter&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0037"> <div class="reference-title-banner"> <h4 class="title">CDA 2008</h4> </div> <div class="bibliography-section" id="CD004136-bib-0142"> <div class="citation-other">Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. <span class="citation-title">Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada</span>. Canadian Journal of Diabetes<span class="pubYear">2008</span>; Vol. 32, issue Suppl 1:S1‐S201. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0038"> <div class="reference-title-banner"> <h4 class="title">Chadban 2010</h4> </div> <div class="bibliography-section" id="CD004136-bib-0143"> <div class="citation-journal">Chadban S, Howell M, Twigg S, Thomas M, Jerums G, Cass A, et al. <span class="citation-title">Prevention and management of chronic kidney disease in type 2 diabetes</span>. <span class="citation"> Nephrology </span><span class="pubYear">2010</span>;<span class="volume">15</span>:S162‐94. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111/j.1440-1797.2010.01240.x" target="_blank"><span>10.1111/j.1440‐1797.2010.01240.x</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/20591029" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prevention+and+management+of+chronic+kidney+disease+in+type+2+diabetes&author=S+Chadban&author=M+Howell&author=S+Twigg&author=M+Thomas&author=G+Jerums&author=A+Cass&publication_year=2010&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0039"> <div class="reference-title-banner"> <h4 class="title">Chaturvedi 2008</h4> </div> <div class="bibliography-section" id="CD004136-bib-0144"> <div class="citation-journal">Chaturvedi N, Porta M, Klein R, Orchard T, Fuller J, Parving HH, et al. <span class="citation-title">Effect of candesartan on prevention (DIRECT‐Prevent 1) and progression (DIRECT‐Protect 1) of retinopathy in type 1 diabetes: randomised, placebo‐controlled trials</span>. <span class="citation"> Lancet </span><span class="pubYear">2008</span>;<span class="volume">372</span>(9647):1394‐402. [MEDLINE: 18823656] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18823656" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+candesartan+on+prevention+(DIRECT%E2%80%90Prevent+1)+and+progression+(DIRECT%E2%80%90Protect+1)+of+retinopathy+in+type+1+diabetes:+randomised,+placebo%E2%80%90controlled+trials+&author=N+Chaturvedi&author=M+Porta&author=R+Klein&author=T+Orchard&author=J+Fuller&author=HH+Parving&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0040"> <div class="reference-title-banner"> <h4 class="title">Chobanian 2003</h4> </div> <div class="bibliography-section" id="CD004136-bib-0145"> <div class="citation-journal">Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. <span class="citation-title">The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report</span>. <span class="citation"> JAMA </span><span class="pubYear">2003</span>;<span class="volume">289</span>(19):2560‐72. [MEDLINE: 12748199] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12748199" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+Seventh+Report+of+the+Joint+National+Committee+on+Prevention,+Detection,+Evaluation,+and+Treatment+of+High+Blood+Pressure:+the+JNC+7+report+&author=AV+Chobanian&author=GL+Bakris&author=HR+Black&author=WC+Cushman&author=LA+Green&author=JL+Izzo&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0041"> <div class="reference-title-banner"> <h4 class="title">ESH‐ESC 2007</h4> </div> <div class="bibliography-section" id="CD004136-bib-0146"> <div class="citation-journal">Mancia G, Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. <span class="citation-title">2007 ESH‐ESC Practice Guidelines for the Management of Arterial Hypertension: ESH‐ESC Task Force on the Management of Arterial Hypertension</span>. <span class="citation"> Journal of Hypertension </span><span class="pubYear">2007</span>;<span class="volume">25</span>(9):1751‐62. [MEDLINE: 17762635] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17762635" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=2007+ESH%E2%80%90ESC+Practice+Guidelines+for+the+Management+of+Arterial+Hypertension:+ESH%E2%80%90ESC+Task+Force+on+the+Management+of+Arterial+Hypertension+&author=G+Mancia&author=G+Backer&author=A+Dominiczak&author=R+Cifkova&author=R+Fagard&author=G+Germano&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0042"> <div class="reference-title-banner"> <h4 class="title">Gerstein 2001</h4> </div> <div class="bibliography-section" id="CD004136-bib-0147"> <div class="citation-journal">Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. <span class="citation-title">Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals</span>. <span class="citation"> JAMA </span><span class="pubYear">2001</span>;<span class="volume">286</span>(4):421‐6. [MEDLINE: 11466120] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11466120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Albuminuria+and+risk+of+cardiovascular+events,+death,+and+heart+failure+in+diabetic+and+nondiabetic+individuals+&author=HC+Gerstein&author=JF+Mann&author=Q+Yi&author=B+Zinman&author=SF+Dinneen&author=B+Hoogwerf&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0043"> <div class="reference-title-banner"> <h4 class="title">Hasslacher 1985</h4> </div> <div class="bibliography-section" id="CD004136-bib-0148"> <div class="citation-journal">Hasslacher C, Ritz E, Terpstra J, Gallasch G, Kunowski G, Rall C. <span class="citation-title">Natural history of nephropathy in type I diabetes. Relationship to metabolic control and blood pressure</span>. <span class="citation"> Hypertension </span><span class="pubYear">1985</span>;<span class="volume">7</span>(6 Pt 2):74‐8. [MEDLINE: 4077240] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Natural+history+of+nephropathy+in+type+I+diabetes.+Relationship+to+metabolic+control+and+blood+pressure+&author=C+Hasslacher&author=E+Ritz&author=J+Terpstra&author=G+Gallasch&author=G+Kunowski&author=C+Rall&publication_year=1985&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0044"> <div class="reference-title-banner"> <h4 class="title">Higgins 2003</h4> </div> <div class="bibliography-section" id="CD004136-bib-0149"> <div class="citation-journal">Higgins JP, Thompson SG, Deeks JJ, Altman DG. <span class="citation-title">Measuring inconsistency in meta‐analyses</span>. <span class="citation"> BMJ </span><span class="pubYear">2003</span>;<span class="volume">327</span>(7414):557‐60. [MEDLINE: 12958120] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12958120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Measuring+inconsistency+in+meta%E2%80%90analyses&author=JP+Higgins&author=SG+Thompson&author=JJ+Deeks&author=DG+Altman&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0045"> <div class="reference-title-banner"> <h4 class="title">Higgins 2011</h4> </div> <div class="bibliography-section" id="CD004136-bib-0150"> <div class="citation-other">Higgins JPT, Green S (editors). <span class="citation-title">Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</span>. Available from www.cochrane‐handbook.org. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0046"> <div class="reference-title-banner"> <h4 class="title">IDF 2009</h4> </div> <div class="bibliography-section" id="CD004136-bib-0151"> <div class="citation-other">International Diabetes Federation. <span class="citation-title">IDF Diabetes Atlas</span>. http://www.idf.org/diabetesatlas/ (accessed 26 September 2012). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0047"> <div class="reference-title-banner"> <h4 class="title">KDOQI 2007</h4> </div> <div class="bibliography-section" id="CD004136-bib-0152"> <div class="citation-other">American Kidney Foundation. <span class="citation-title">KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease</span>. http://www.kidney.org/professionals/KDOQI/guideline_diabetes/guide3.htm (accessed 26 September 2012). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0048"> <div class="reference-title-banner"> <h4 class="title">Klausen 2004</h4> </div> <div class="bibliography-section" id="CD004136-bib-0153"> <div class="citation-journal">Klausen K, Borch‐Johnsen K, Feldt‐Rasmussen B, Jensen G, Clausen P, Scharling H, et al. <span class="citation-title">Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes</span>. <span class="citation"> Circulation </span><span class="pubYear">2004</span>;<span class="volume">110</span>(1):32‐5. [MEDLINE: 15210602] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15210602" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Very+low+levels+of+microalbuminuria+are+associated+with+increased+risk+of+coronary+heart+disease+and+death+independently+of+renal+function,+hypertension,+and+diabetes+&author=K+Klausen&author=K+Borch%E2%80%90Johnsen&author=B+Feldt%E2%80%90Rasmussen&author=G+Jensen&author=P+Clausen&author=H+Scharling&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0049"> <div class="reference-title-banner"> <h4 class="title">Levey 2009</h4> </div> <div class="bibliography-section" id="CD004136-bib-0154"> <div class="citation-journal">Levey AS, Cattran D, Friedman A, Miller WG, Sedor J, Tuttle K, et al. <span class="citation-title">Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration</span>. <span class="citation"> American Journal of Kidney Diseases </span><span class="pubYear">2009</span>;<span class="volume">54</span>(2):205‐26. [MEDLINE: 19577347] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19577347" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Proteinuria+as+a+surrogate+outcome+in+CKD:+report+of+a+scientific+workshop+sponsored+by+the+National+Kidney+Foundation+and+the+US+Food+and+Drug+Administration+&author=AS+Levey&author=D+Cattran&author=A+Friedman&author=WG+Miller&author=J+Sedor&author=K+Tuttle&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0050"> <div class="reference-title-banner"> <h4 class="title">Messent 1992</h4> </div> <div class="bibliography-section" id="CD004136-bib-0155"> <div class="citation-journal">Messent JW, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. <span class="citation-title">Prognostic significance of microalbuminuria in insulin‐dependent diabetes mellitus: a twenty‐three year follow‐up study</span>. <span class="citation"> Kidney International </span><span class="pubYear">1992</span>;<span class="volume">41</span>(4):836‐9. [MEDLINE: 1513106] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/1513106" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Prognostic+significance+of+microalbuminuria+in+insulin%E2%80%90dependent+diabetes+mellitus:+a+twenty%E2%80%90three+year+follow%E2%80%90up+study+&author=JW+Messent&author=TG+Elliott&author=RD+Hill&author=RJ+Jarrett&author=H+Keen&author=GC+Viberti&publication_year=1992&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0051"> <div class="reference-title-banner"> <h4 class="title">Mogensen 1976</h4> </div> <div class="bibliography-section" id="CD004136-bib-0156"> <div class="citation-journal">Mogensen CE. <span class="citation-title">Progression of nephropathy in long‐term diabetics with proteinuria and effect of initial anti‐hypertensive treatment</span>. <span class="citation"> Scandinavian Journal of Clinical &amp; Laboratory Investigation </span><span class="pubYear">1976</span>;<span class="volume">36</span>(4):383‐8. [MEDLINE: 959756] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Progression+of+nephropathy+in+long%E2%80%90term+diabetics+with+proteinuria+and+effect+of+initial+anti%E2%80%90hypertensive+treatment+&author=CE+Mogensen&publication_year=1976&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0052"> <div class="reference-title-banner"> <h4 class="title">Ninomiya 2009</h4> </div> <div class="bibliography-section" id="CD004136-bib-0157"> <div class="citation-journal">Ninomiya T, Perkovic V, Galan BE, Zoungas S, Pillai A, Jardine M, et al. <span class="citation-title">Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes</span>. <span class="citation"> Journal of the American Society of Nephrology </span><span class="pubYear">2009</span>;<span class="volume">20</span>(8):1813‐21. [MEDLINE: 19443635] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19443635" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Albuminuria+and+kidney+function+independently+predict+cardiovascular+and+renal+outcomes+in+diabetes+&author=T+Ninomiya&author=V+Perkovic&author=BE+Galan&author=S+Zoungas&author=A+Pillai&author=M+Jardine&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0053"> <div class="reference-title-banner"> <h4 class="title">Parfrey 2009</h4> </div> <div class="bibliography-section" id="CD004136-bib-0158"> <div class="citation-journal">Parfrey PS. <span class="citation-title">Angiotensin‐receptor blockers in the prevention or treatment of microalbuminuria</span>. <span class="citation"> Annals of Internal Medicine </span><span class="pubYear">2009</span>;<span class="volume">151</span>(1):63‐5. [MEDLINE: 19581647] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/19581647" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Angiotensin%E2%80%90receptor+blockers+in+the+prevention+or+treatment+of+microalbuminuria&author=PS+Parfrey&publication_year=2009&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0054"> <div class="reference-title-banner"> <h4 class="title">Perkovic 2008</h4> </div> <div class="bibliography-section" id="CD004136-bib-0159"> <div class="citation-journal">Perkovic V, Verdon C, Ninomiya T, Barzi F, Cass A, Patel A, et al. <span class="citation-title">The relationship between proteinuria and coronary risk: a systematic review and meta‐analysis</span>. <span class="citation"> PLoS Medicine / Public Library of Science </span><span class="pubYear">2008</span>;<span class="volume">5</span>(10):e207. [MEDLINE: 18942886] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18942886" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+relationship+between+proteinuria+and+coronary+risk:+a+systematic+review+and+meta%E2%80%90analysis&author=V+Perkovic&author=C+Verdon&author=T+Ninomiya&author=F+Barzi&author=A+Cass&author=A+Patel&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0055"> <div class="reference-title-banner"> <h4 class="title">Ritz 1999</h4> </div> <div class="bibliography-section" id="CD004136-bib-0160"> <div class="citation-journal">Ritz E, Orth SR. <span class="citation-title">Nephropathy in patients with type 2 diabetes mellitus</span>. <span class="citation"> New England Journal of Medicine </span><span class="pubYear">1999</span>;<span class="volume">341</span>(15):1127‐33. [MEDLINE: 10511612] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10511612" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Nephropathy+in+patients+with+type+2+diabetes+mellitus&author=E+Ritz&author=SR+Orth&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0056"> <div class="reference-title-banner"> <h4 class="title">Ruggenenti 1997</h4> </div> <div class="bibliography-section" id="CD004136-bib-0161"> <div class="citation-journal">Ruggenenti P, Remuzzi G. <span class="citation-title">The diagnosis of renal involvement in non‐insulin‐dependent diabetes mellitus</span>. <span class="citation"> Current Opinion in Nephrology &amp; Hypertension </span><span class="pubYear">1997</span>;<span class="volume">6</span>(2):141‐5. [MEDLINE: 9146975] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+diagnosis+of+renal+involvement+in+non%E2%80%90insulin%E2%80%90dependent+diabetes+mellitus&author=P+Ruggenenti&author=G+Remuzzi&publication_year=1997&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0057"> <div class="reference-title-banner"> <h4 class="title">Sjølie 2008</h4> </div> <div class="bibliography-section" id="CD004136-bib-0162"> <div class="citation-journal">Sjølie AK, Klein R, Porta M, Orchard T, Fuller J, Parving HH, et al. <span class="citation-title">Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT‐Protect 2): a randomised placebo‐controlled trial</span>. <span class="citation"> Lancet </span><span class="pubYear">2008</span>;<span class="volume">372</span>(9647):1385‐93. [MEDLINE: 18823658] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/18823658" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+candesartan+on+progression+and+regression+of+retinopathy+in+type+2+diabetes+(DIRECT%E2%80%90Protect+2):+a+randomised+placebo%E2%80%90controlled+trial+&author=AK+Sj%C3%B8lie&author=R+Klein&author=M+Porta&author=T+Orchard&author=J+Fuller&author=HH+Parving&publication_year=2008&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0058"> <div class="reference-title-banner"> <h4 class="title">Song 2000</h4> </div> <div class="bibliography-section" id="CD004136-bib-0163"> <div class="citation-journal">Song F, Glenny AM, Altman DG. <span class="citation-title">Indirect comparison in evaluating relative efficacy illustrated by antimicrobial prophylaxis in colorectal surgery</span>. <span class="citation"> Controlled Clinical Trials </span><span class="pubYear">2000</span>;<span class="volume">21</span>(5):488‐97. [MEDLINE: 11018565] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11018565" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Indirect+comparison+in+evaluating+relative+efficacy+illustrated+by+antimicrobial+prophylaxis+in+colorectal+surgery+&author=F+Song&author=AM+Glenny&author=DG+Altman&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0059"> <div class="reference-title-banner"> <h4 class="title">Strippoli 2004</h4> </div> <div class="bibliography-section" id="CD004136-bib-0164"> <div class="citation-journal">Strippoli GF, Craig M, Deeks JJ, Schena FP, Craig JC. <span class="citation-title">Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review</span>. <span class="citation"> BMJ </span><span class="pubYear">2004</span>;<span class="volume">329</span>(7370):828‐31. [MEDLINE: 15459003] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15459003" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+angiotensin+converting+enzyme+inhibitors+and+angiotensin+II+receptor+antagonists+on+mortality+and+renal+outcomes+in+diabetic+nephropathy:+systematic+review+&author=GF+Strippoli&author=M+Craig&author=JJ+Deeks&author=FP+Schena&author=JC+Craig&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0060"> <div class="reference-title-banner"> <h4 class="title">USRDS 2009</h4> </div> <div class="bibliography-section" id="CD004136-bib-0165"> <div class="citation-other">U S Renal Data System. <span class="citation-title">USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End‐Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2009</span>. http://www.usrds.org/atlas09.aspx (accessed 25 September 2012). <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD004136-bbs2-0061"> <div class="reference-title-banner"> <h4 class="title">Williams 2004</h4> </div> <div class="bibliography-section" id="CD004136-bib-0166"> <div class="citation-journal">Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. <span class="citation-title">British Hypertension Society guidelines for hypertension management 2004 (BHS‐IV): summary</span>. <span class="citation"> BMJ </span><span class="pubYear">2004</span>;<span class="volume">328</span>(7440):634‐40. [MEDLINE: 15016698] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15016698" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=British+Hypertension+Society+guidelines+for+hypertension+management+2004+(BHS%E2%80%90IV):+summary+&author=B+Williams&author=NR+Poulter&author=MJ+Brown&author=M+Davis&author=GT+McInnes&author=JF+Potter&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD004136-bbs1-0004"> <h3 class="title">References to other published versions of this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD004136-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD004136-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD004136-bbs1-0003">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_otherVersions" id="CD004136-bbs2-0062"> <div class="reference-title-banner"> <h4 class="title">Strippoli 2003</h4> </div> <div class="bibliography-section" id="CD004136-bib-0167"> <div class="citation-journal">Strippoli GFM, Craig M, Schena FP, Craig JC. <span class="citation-title">Antihypertensive agents for preventing diabetic kidney disease. (Protocol)</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2003</span>, Issue 2. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD004136" target="_blank"><span>10.1002/14651858.CD004136</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antihypertensive+agents+for+preventing+diabetic+kidney+disease.+(Protocol)&author=GFM+Strippoli&author=M+Craig&author=FP+Schena&author=JC+Craig&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_otherVersions" id="CD004136-bbs2-0063"> <div class="reference-title-banner"> <h4 class="title">Strippoli 2005</h4> </div> <div class="bibliography-section" id="CD004136-bib-0168"> <div class="citation-journal">Strippoli GF, Craig M, Craig JC. <span class="citation-title">Antihypertensive agents for preventing diabetic kidney disease</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2005</span>, Issue 4. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD004136.pub2" target="_blank"><span>10.1002/14651858.CD004136.pub2</span></a>] <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Antihypertensive+agents+for+preventing+diabetic+kidney+disease&author=GF+Strippoli&author=M+Craig&author=JC+Craig&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> </section> </section> <section class="characteristicStudies" id="characteristicStudies"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title"> Characteristics of studies <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="characteristicIncludedStudiesContent" lang=""> <div class="section-header" id="CD004136-sec2-0019"> <h3 class="title">Characteristics of included studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD004136-sec2-0020" class="jump-to">excluded studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">ABCD Study 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0009"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up period: 63.6 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0010"> <li> <p>Country: USA</p> </li> <li> <p>Setting: University</p> </li> <li> <p>Proportion of diabetic subjects with normoalbuminuria, microalbuminuria or macroalbuminuria not available; all type 2 diabetes; all hypertensive </p> </li> <li> <p>Number: treatment group (119); control group (127)</p> </li> <li> <p>Mean age ± SD (years): treatment group (8.8 ± 6.3); control group (9.2 ± 7.6)</p> </li> <li> <p>Sex (M/F): 131/115</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0011"> <li> <p>Known allergy to dihydropyridines or ACEi; a myocardial infarction or cerebral vascular accident within the previous 6 months; coronary artery bypass surgery within the previous 3 months; unstable angina pectoris within the previous 6 months; Class III or IV New York Heart Association classification of congestive heart failure; demonstrated an absolute need for ACEi or calcium channel blockers; receiving haemo‐ or peritoneal dialysis and/or had a SCr &gt; 3 mg/dL </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0012"> <li> <p>Enalapril: 5 to 40 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0013"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0014"> <li> <p>Death</p> </li> <li> <p>Cardiovascular death</p> </li> <li> <p>Myocardial infarction</p> </li> <li> <p>BP</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0015"> <li> <p>BP target equalisation not achieved in study (no use of other antihypertensive co‐interventions)</p> </li> <li> <p>End of treatment HbA1c not available</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Using permuted block randomisation within strata</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Assignment through telephone by the coordinator centres</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Placebo was used; study nurses were blinded to the use of enalapril versus nisoldipine, but could not be blinded with respect to intensive versus moderate BP control. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Endpoint committee were blinded to the patient assignment</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported the pre‐specified outcomes in the protocol. Albuminuria change was not reported in detail for the data to be included in the meta‐analysis </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">ABCD‐2V Study 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0016"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up period: 22.8 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0017"> <li> <p>Country: USA</p> </li> <li> <p>Setting: single centre, university</p> </li> <li> <p>Diabetic subjects with normoalbuminuria (102), microalbuminuria (26), macroalbuminuria (1); all type 2 diabetes; all normotensive </p> </li> <li> <p>Number: treatment group (66); control group (63)</p> </li> <li> <p>Mean age ± SD (years): treatment group (56.7 ± 7.7); control group (55.5 ± 7.7)</p> </li> <li> <p>Sex (M/F): treatment group (44/22); control group (43/20)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0018"> <li> <p>Pregnant or lactating women; need for any antihypertensive medications; documented myocardial infarction or cerebrovascular accident within the past 6 months; severe peripheral vascular disease; history of bilateral renal artery stenosis or stenosis in a solitary kidney; evidence of severe liver disease; hyperkalaemia; history of active cancer </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0019"> <li> <p>Valsartan: 80 to 160 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0020"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0021"> <li> <p>Death</p> </li> <li> <p>Cardiovascular event</p> </li> <li> <p>BP</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0022"> <li> <p>BP target equalization not achieved in study</p> </li> <li> <p>Change in end of treatment HbA1c ‐0.67% versus ‐0.33% in treatment and control group</p> </li> <li> <p>'Study terminated due to funding restraints The extended recruitment period (4 years) and study termination after a total of 5 years resulted in a differential follow‐up ranging from 1 year to 4 years, with 12 patients having 4 years of follow‐up. The mean follow‐up was 1.9 ± 1.0 years for the study group. Because the follow‐up period was shorter than anticipated and did not reach the initial study recruitment goals, the primary outcome was redefined as the change in UAE. The progression/regression of retinopathy and neuropathy as well as the incidence of cardiovascular events were also evaluated' </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Generated the randomisation list using SAS, stratified by sex and SCr</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomisation list was secured within the Data Coordinating Center</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Placebo was used; the study nurses by necessity knew the BP treatment categories for their individual patients </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Endpoint committee was blinded to the intervention arm</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Five patients were lost follow‐up, and comparable between the two intervention arms (2 in intervention group and 3 in the control group) </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reporting all outcomes that described in the method. Albuminuria change was not reported in detail for the data to be included in the meta‐analysis </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">ADVANCE Study 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0023"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up: 51.6 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0024"> <li> <p>Country: 20 countries</p> </li> <li> <p>Setting: 215 collaborating clinical centres</p> </li> <li> <p>Diabetic subjects with normoalbuminuria (7877), microalbuminuria (2862), macroalbuminuria (401); 68.7% were hypertensive; all type 2 diabetes </p> </li> <li> <p>Number: treatment group (5569); control group (5571)</p> </li> <li> <p>Mean age ± SD (years): treatment group (66 ± 6); control group (66 ± 7)</p> </li> <li> <p>Sex (M/F): treatment group (3203/2366); control group (3202/2369)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0025"> <li> <p>Indication for long‐term insulin therapy</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0026"> <li> <p>Perindopril: 4 mg</p> </li> <li> <p>Indapamide: 1.25 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0027"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0028"> <li> <p>Death</p> </li> <li> <p>ESKD</p> </li> <li> <p>Doubling SCR</p> </li> <li> <p>New onset of albuminuria</p> </li> <li> <p>BP</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0029"> <li> <p>Additional outcome data obtained from author</p> </li> <li> <p>BP target equalization not achieved in study</p> </li> <li> <p>No difference in end of treatment HbA1c values</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Centre randomisation stratified by study centre, history macrovascular/microvascular disease and and background use of perindopril at baseline </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomisation service accessible by Internet, telephone, and facsimile.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double blind fashion</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>An Endpoint Adjudication Committee was masked to treatment allocation</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Only 15 patients (0.1%) were lost follow‐up, 4 in the intervention group and 11 in the placebo group </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported all the outcomes described in the protocol</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Baba 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0030"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up: 24 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0031"> <li> <p>Country: Japan</p> </li> <li> <p>Setting: multicentre study</p> </li> <li> <p>Proportion of diabetic subjects with normo or micro/macroalbuminuria in study not available; all had type 2 diabetes; all were hypertensive </p> </li> <li> <p>Number: treatment group (208); control group (228)</p> </li> <li> <p>Mean age ± SD (years): treatment group (60.2 ± 8.9); control group (59.9 ± 8.6)</p> </li> <li> <p>Sex (M/F): treatment group (111/117); control group (109/99)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0032"> <li> <p>Poor glycaemic control (HbA1c 12%); malignant hypertension; renal artery stenosis; overt proteinuria </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0033"> <li> <p>Enalapril: 5 to 20 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0034"> <li> <p>Nifedipine: 20 to 60 mg/d</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0035"> <li> <p>Death</p> </li> <li> <p>ESKD</p> </li> <li> <p>Doubling of SCr</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0036"> <li> <p>Additional outcome data obtained from author</p> </li> <li> <p>BP target equalization achieved in study by use of other antihypertensive co‐interventions</p> </li> <li> <p>No difference in end of treatment HbA1c values</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'A block of 4 patients (2 per group) was assigned'. Possible generated by computer or randomisation table. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'envelope method was used'. Allocation concealment was probably done</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>open‐label</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>reported all the pre‐specified outcomes</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">BENEDICT Study 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0037"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up: 36 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0038"> <li> <p>Country: Italy</p> </li> <li> <p>Setting: multicentre (9 diabetic clinics)</p> </li> <li> <p>Diabetic subjects with normoalbuminuria; all type 2 diabetes; all hypertensive</p> </li> <li> <p>Number: treatment group (301); control group 1 (300); control group 2 (300); control group 3 (300) </p> </li> <li> <p>Mean age ± SD (years): treatment group 1 (61.6 ± 8.1); treatment group 2 (62.5 ± 8.2); treatment group 3 (62.7 ± 7.7); control group (62.6 ± 8.2) </p> </li> <li> <p>Sex (M/F): treatment group 1 (157/144); treatment group 2 (164/139); treatment group 3 (165/135); control group (149/151) </p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0039"> <li> <p>Concomitant non‐DKD; concomitant diseases (heart failure, stroke, TIA, acute myocardial infarction, unstable angina in the last 3 months, severe or secondary hypertension, cancer, systemic disease, severe hematological or liver disorder, malabsorption, and any major clinical condition that may jeopardize study participation); specific contraindications to the study drugs; inability to provide informed consent </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group 1</p> <p> <ul id="CD004136-lst1-0040"> <li> <p>Trandolapril: 2 mg/d</p> </li> </ul> </p> <p>Treatment group 2</p> <p> <ul id="CD004136-lst1-0041"> <li> <p>Verapamil SR: 240 mg/d</p> </li> </ul> </p> <p>treatment group 3</p> <p> <ul id="CD004136-lst1-0042"> <li> <p>Trandolapril: 2 mg/d</p> </li> <li> <p>Verapamil: 180 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0043"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0044"> <li> <p>Onset of microalbuminuria</p> </li> <li> <p>All‐cause mortality</p> </li> <li> <p>Cough</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0045"> <li> <p>BP target equalization achieved in study by use of other antihypertensive co‐interventions</p> </li> <li> <p>End of treatment HbA1c not available</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'a multicenter, double‐blind, placebo‐controlled, randomised study'. Data analysts were unblinded </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1204 (99.7%) were followed for a median of 3.6 years. Only 0.3% of the patients with lost during the follow‐up </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported all outcomes described in the methods</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">CALM II Study 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0046"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up: 12 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0047"> <li> <p>Country: Denmark</p> </li> <li> <p>Setting: single centre</p> </li> <li> <p>Diabetic subjects with normoalbuminuria (45), microalbuminuria (36); type 1 diabetes (11); type 2 diabetes (63); all hypertensive </p> </li> <li> <p>Number: treatment group (37); control group (38)</p> </li> <li> <p>Mean age ± SD (years): treatment group (56 ± 9); control group (54 ± 9)</p> </li> <li> <p>Sex (M/F): treatment group (26/11); control group (30/8)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0048"> <li> <p>Age &lt; 18 and &gt; 75 years; nondiabetic cause of secondary hypertension or malignant hypertension; cardiovascular events within 6 months before randomisation; impaired renal function with a SCr 130 mol/L or plasma potassium outside normal range; pregnancy or breast feeding </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0049"> <li> <p>Lisinopril: 40 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0050"> <li> <p>Lisinopril: 20 mg/d</p> </li> <li> <p>Candesartan: 16 mg/d</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0051"> <li> <p>BP</p> </li> <li> <p>Albuminuria</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0052"> <li> <p>Additional outcome data obtained from author</p> </li> <li> <p>BP target equalization achieved in study by use of other antihypertensive co‐interventions</p> </li> <li> <p>End of treatment HbA1c: treatment group (8.6%); control group (8.0%)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'double‐blind, randomised, active‐controlled, parallel group study', probably done</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All patients followed the treatment protocol and were available for follow‐up.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>In the protocol the outcomes included retinopathy and left ventricular mass, but only albuminuria and BP were reported here </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Chan 1992 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0053"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up: 66 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0054"> <li> <p>Setting: single university centre</p> </li> <li> <p>Country: China</p> </li> <li> <p>All type 2 diabetes; all hypertensive; all treated with diet or oral agents, and none were receiving insulin treatment or lipid‐lowering drugs at the time of recruitment </p> </li> <li> <p>Number: treatment group (50); control group (52)</p> <ul id="CD004136-lst2-0005"> <li> <p>Normoalbuminuria: treatment group (20); control group (24)</p> </li> <li> <p>Microalbuminuria: treatment group (21); control group (15)</p> </li> </ul> </li> <li> <p>Mean age ± SD (years): treatment group (60 ± 9.3); control group (56.2 ± 9.9)</p> </li> <li> <p>Sex (M/F): treatment group (20/30); control group (21/31)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0055"> <li> <p>Receiving insulin; history of non‐DKD; SCr ≥ 200 mol/L; plasma potassium concentration ≥ 5 mmol/L; cardiac failure; any concurrent systemic disease; receiving treatment for any concomitant disorder </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0056"> <li> <p>Enalapril: 10‐40 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0057"> <li> <p>Nifedipine SF: 40‐80 mg/d</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0058"> <li> <p>Death</p> </li> <li> <p>BP</p> </li> <li> <p>Albuminuria</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0059"> <li> <p>BP target equalisation achieved in study by use of other antihypertensive co‐interventions</p> </li> <li> <p>End of treatment HbA1c: treatment group (7.6%); control group (7.1%)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'according to a random allocation schedule. A schedule of 102 allocation numbers corresponding to similarly numbered drug supplies was provided for this purpose.' No description of how random sequence was produced </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No description of how allocation was performed</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Patients blinded; blinding of investigators not stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"staff measuring BP and biochemical indices were blinded to treatment."</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Detailed description of the reasons of the 9 patients (8.8%) who did not finish follow‐up</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported all outcomes described in methods</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Crepaldi 1995 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0060"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up: 6 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0061"> <li> <p>Country: Italy</p> </li> <li> <p>Setting: multicentre (12) anti‐diabetic centres</p> </li> <li> <p>Men and women &lt; 70 years with mild to moderate hypertension (phase V supine DPB 90‐115 mm Hg) and non‐insulin‐dependent diabetes (normoalbuminuria (55), microalbuminuria (24)); all type 2 diabetes; all hypertensive </p> </li> <li> <p>Treatment group</p> </li> <li> <p>Number: treatment group (83); control group (79)</p> </li> <li> <p>Mean age ± SD (years)</p> <ul id="CD004136-lst2-0006"> <li> <p>Treatment group: males (54.7 ± 8.1); females (56.8 ± 7.9)</p> </li> <li> <p>Control group: males (56.3 ± 8.6); females (57.5 ± 9.0)</p> </li> </ul> </li> <li> <p>Sex (M/F): treatment group (40/43); control group (38/41)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0062"> <li> <p>Secondary or malignant hypertension; a recent history of myocardial infarction; unstable angina; heart failure or aortic; outflow obstruction; renal, hepatic, blood or endocrine disorders other than diabetes; positive response to an Albustix test for urinary protein; women capable of becoming pregnant or using oral contraceptives; history of poor compliance with drug therapy; known hypersensitivity/contraindication to ACEi or nifedipine. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0063"> <li> <p>Lisinopril: 10‐20 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0064"> <li> <p>Nifedipine: 20‐60 mg/d</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0065"> <li> <p>Death</p> </li> <li> <p>ESKD</p> </li> <li> <p>BP</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0066"> <li> <p>BP target equalization not achieved in study (no use of other antihypertensive co‐interventions)</p> </li> <li> <p>Change in end of treatment HbA1c: treatment group (‐0.4%); control group (‐0.2%)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"The randomization process was carried out by the coordinating centre using standard randomization techniques." No description of the generation of random sequence </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No description of allocation concealment</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'double‐blind, double‐dummy, randomised trial'</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>171 patients qualified for admittance to the study, of whom 9 withdrew during the placebo, run‐in phase. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Described all the outcomes pre‐specified in the methods. Albuminuria change was not reported in detail for the data to be included in a meta‐analysis </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">DIRECT Studies 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0067"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Recruitment: commenced in August 2001, and the last patient was studied in March 2008.</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0068"> <li> <p>Setting: international multicentre (309 centres)</p> </li> <li> <p>Countries: 30 countries</p> </li> <li> <p>DIRECT‐Prevent 1</p> <ul id="CD004136-lst2-0007"> <li> <p>Diabetic subjects with normoalbuminuria (1421); all type 1 diabetes; all normotensive; no difference in end of treatment HbA1c values </p> </li> <li> <p>Number: treatment group (711); control group (710)</p> </li> <li> <p>Mean age ± SD (years): treatment group (29.6 ± 8.0); control group (29.9 ± 8.1)</p> </li> <li> <p>Sex (M/F): treatment group (413/298); control group (392/318)</p> </li> </ul> </li> <li> <p>DIRECT‐Protect 1</p> <ul id="CD004136-lst2-0008"> <li> <p>Diabetic subjects with normoalbuminuria (1905); all type 1 diabetes; all normotensive; no difference in end of treatment HbA1c values </p> </li> <li> <p>Number: treatment group (951); control group (954)</p> </li> <li> <p>Mean age ± SD (years): treatment group (35.1 ± 8.5); control group (31.9 ± 8.5)</p> </li> <li> <p>Sex (M/F): treatment group (538/413); control group (553/401)</p> </li> </ul> </li> </ul> <ul id="CD004136-lst1-0069"> <li> <p>DIRECT‐Protect 2</p> <ul id="CD004136-lst2-0009"> <li> <p>Diabetic subjects with normoalbuminuria (1905); all type 2 diabetes; 62% with hypertensive; no difference in end of treatment HbA1c values </p> </li> <li> <p>Number: treatment group (951); control group (954)</p> </li> <li> <p>Mean age ± SD (years): treatment group (56.9 ± 7.6); control group (56.8 ± 7.9)</p> </li> <li> <p>Sex (M/F): treatment group (466/485); control group (482/472)</p> </li> </ul> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0070"> <li> <p>Cataract or media opacity; angle closure glaucoma; history of retinopathy; history or presence of clinical significant macular oedema; history or evidence of photocoagulation of the retina; other retinal conditions which may mask assessment; pregnant or lactating women or women of child bearing potential not practicing an adequate method of contraception; need of treatment with ACEi; haemodynamically significant aortic or mitral valve stenosis; known renal artery stenosis or kidney transplantation; hypersensitivity to study drug; severe concomitant disease which may interfere with the assessment of the patient; malignancy </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0071"> <li> <p>Candesartan: 16 mg/d increasing to 32 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0072"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0073"> <li> <p>Death</p> </li> <li> <p>New onset albuminuria</p> </li> <li> <p>BP</p> </li> <li> <p>headache</p> </li> <li> <p>hyperkalaemia</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0074"> <li> <p>Supported By AstraZeneca and Takeda</p> </li> <li> <p>Statistical staff at AstraZeneca and Takeda did analyses according to the intention‐to‐treat principle. The 2‐sided P values were calculated without any adjustment for multiple comparisons </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomisation into the three studies was conducted based on primary grading of the baseline photographs, using the ETDRS severity scale.The patients are to be evaluated in the correct study based on the final grading of the photographs. </p> <p>No description of random sequence generation</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"randomly assigned eligible patients centrally using an interactive voice‐response system" </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'double‐masked, placebo‐controlled, parallel design, randomised clinical trials'</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>286/1662 (17.2%) missing from intervention group; 272/1664 (16.3%) missing from control group. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reporting all the outcomes of pre‐specified in the methods</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">EUCLID Study 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0075"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up: 24 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0076"> <li> <p>Setting: multicentre (18 centres)</p> </li> <li> <p>Country: Europe</p> </li> <li> <p>Diabetic subjects normoalbuminuria (227), microalbuminuria (34), macroalbuminuria (269); all type 1 diabetes; all normotensive </p> </li> <li> <p>Number: treatment group (265); control group (265)</p> </li> <li> <p>Age, range (years): treatment group (33, 27‐40); control group (33, 28‐41)</p> </li> <li> <p>Sex (M/F): treatment group (155/110); control group (167/98)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0077"> <li> <p>History of renal‐artery stenosis, cardiac‐valve obstruction, or accelerated hypertension; recent (previous 3 months) myocardial infarction, coronary bypass surgery, stroke, or congestive cardiac failure; abnormal renal function (SCr &gt; 150 mol/L, &gt; 1·8 mg/dL) in the previous 6 months, persistent proteinuria or persistent haematuria on 3 occasions within the previous 12 months; postural hypotension, medication that affects BP, a previous idiosyncratic reaction to ACEi; seropositivity for hepatitis B or HIV </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0078"> <li> <p>Lisinopril: 10‐20 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0079"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0080"> <li> <p>Death</p> </li> <li> <p>HbA1c</p> </li> <li> <p>AER</p> </li> <li> <p>BP</p> </li> <li> <p>Serious adverse events (hospital admission, hypoglycaemia, withdrawal due to treatment)</p> </li> <li> <p>Compliance</p> </li> <li> <p>Cough</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0081"> <li> <p>End of treatment HbA1c not available</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>FORTRAN computer program validated against the SAS RANUNI random‐number generator. Randomisation was stratified by centre and albuminuric status. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sealed envelopes were supplied to each centre</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>"This scheme was generated by Zeneca Pharmaceuticals, so that both the coordinating centre and the local investigators were unaware of the allocation." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blood and urine samples were sent to the laboratory of the Royal London Hospital, UK. Laboratory investigators were given the identification number only of the patient." </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42/365 (15.8%) missing from intervention group; 40/265 (15.1%) missing from control group </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported outcomes specified in the methods (death not reported but there may not have been any) </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">FACET Study 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0082"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Recruitment: 1 January 1992 to 31 December 1992</p> </li> <li> <p>Follow‐up: 72 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0083"> <li> <p>Setting: teaching hospital</p> </li> <li> <p>Country: Italy</p> </li> <li> <p>Diabetic subjects, microalbuminuria (380); type 1 and type 2 diabetes; all hypertensive</p> </li> <li> <p>Number: treatment group (189); control group (191)</p> </li> <li> <p>Mean age ± SD (years): treatment group (10.7 ± 9.96); control group (63.3 ± 5.52)</p> </li> <li> <p>Sex (M/F): treatment group (120/69); control group (106/85)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0084"> <li> <p>history of coronary heart disease, stroke, or any other morbid condition with poor prognosis; SCr &gt; 1.5 mg/dL; a microalbuminurialevel &gt; 40 ug/min; use of lipid lowering drugs, aspirin, or antihypertensive agents other than diuretics and beta‐blockers </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0085"> <li> <p>Fosinopril: 20 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0086"> <li> <p>Amlodipine: 10 mg/d</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0087"> <li> <p>Death</p> </li> <li> <p>Myocardial infarction</p> </li> <li> <p>BP</p> </li> <li> <p>Albuminuria</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0088"> <li> <p>BP target equalization not achieved in study (despite use of other antihypertensive co‐interventions) </p> </li> <li> <p>End of treatment HbA1c: treatment group (8.7%); control group (8.5%)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Computer‐generated random number sequence</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Adequate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open‐label design</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17/189 (9.0%) missing from treatment group; 23/191(12.0%) missing from control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported all outcomes specified in the methods</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">HOPE Study 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0089"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Recruitment: December 1993 to June 1995</p> </li> <li> <p>Follow‐up: 72 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0090"> <li> <p>Setting: multicentre study (129 centres)</p> </li> <li> <p>Countries: 19 (Canada, USA, 14 European countries, Argentina, Brazil, Mexico)</p> </li> <li> <p>Type 1 and type 2 (3546) diabetic subjects, normoalbuminuria (2438), microalbuminuria (1139); all hypertensive </p> </li> <li> <p>Treatment group</p> </li> <li> <p>Number: treatment group (1808); control group (1769)</p> </li> <li> <p>Mean age ± SD (years): treatment group (63.6 ± 6.4); control group (65.6 ± 6.6)</p> </li> <li> <p>Sex: M/F: treatment group (1112/696); control group (626/1143)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0091"> <li> <p>Dipstick‐positive proteinuria or established DKD; other severe kidney disease; hyperkalaemia; congestive heart failure; low ejection fraction (&lt; 0.4); uncontrolled hypertension; recent myocardial infarction or stroke (&lt; 4 weeks); use of or hypersensitivity to vitamin E or ACEi </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0092"> <li> <p>Ramipril: 10 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0093"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0094"> <li> <p>Death</p> </li> <li> <p>Cardiovascular death</p> </li> <li> <p>ESKD</p> </li> <li> <p>Doubling of SCr</p> </li> <li> <p>Onset of microalbuminuria</p> </li> <li> <p>Toxicity</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0095"> <li> <p>Additional outcome data obtained from author</p> </li> <li> <p>BP target equalization not achieved in study (despite use of other antihypertensive co‐interventions) </p> </li> <li> <p>End of treatment HbA1c: treatment group (8.7%); control group (8.5%)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Central randomisation (2 x 2 factorial design), no description of the random sequence generation </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'Double‐blind'</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported all outcomes specified in the methods</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Joglekar 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0096"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up: 6 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0097"> <li> <p>Setting: multicentre (20)</p> </li> <li> <p>Country: India</p> </li> <li> <p>Proportion with normoalbuminuria, microalbuminuria or macroalbuminuria not available; all type 2 diabetes; all hypertensive </p> </li> <li> <p>Treatment group</p> </li> <li> <p>Number: treatment group (48); control group (41)</p> </li> <li> <p>Mean age ± SD (years): treatment group (54.7 ± 11.6); control group (53.4 ± 11.6)</p> </li> <li> <p>Sex (M/F): treatment group (17/12); control group (19/12)</p> </li> </ul> </p> <p>Exclusion criteria: not stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0098"> <li> <p>Enalapril: 5‐10 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0099"> <li> <p>Prazosin GITS: 2.5‐5 mg/d</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0100"> <li> <p>Cough</p> </li> <li> <p>GFR</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0101"> <li> <p>BP target equalization not achieved in study (no use of other antihypertensive co‐interventions)</p> </li> <li> <p>End of treatment HbA1c not available</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No description of allocation concealment</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17/48 missing from intervention group; 12/41 missing from control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Albuminuria change was not reported in detail for the data to be included in a meta‐analysis</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kavgaci 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0102"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up: 6 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0103"> <li> <p>Setting: single centre</p> </li> <li> <p>Country: Turkey</p> </li> <li> <p>Diabetic subjects, normoalbuminuria (18), microalbuminuria (15); all type 2 diabetes; all hypertensive </p> </li> <li> <p>Number: treatment group (20); control group (13)</p> </li> <li> <p>Median age, range (years): treatment group (49, 41‐62); control group (59, 40‐66)</p> </li> <li> <p>Sex (M/F): treatment group (9/11); control group (4/19)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0104"> <li> <p>Albuminuria level &gt; 300 mg/d; CCr &lt; 100 mL/min; patients taking ACEi and ARB</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0105"> <li> <p>Fosinopril: 10 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0106"> <li> <p>Losartan: 50 mg/d</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0107"> <li> <p>changes in albuminuria</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0108"> <li> <p>BP target equalization achieved in study by use of other antihypertensive co‐interventions</p> </li> <li> <p>End of treatment HbA1c 7.57 versus 6.58% in treatment and control group</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open‐label</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All of the patients completed the 6 months study period</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Albuminuria change in the patients with normoalbuminuria reported but with inadequate detail for the data to be included in a meta‐analysis </p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kvetny 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0109"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up duration: 36 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0110"> <li> <p>Setting: single hospital</p> </li> <li> <p>Country: Denmark</p> </li> <li> <p>Type 1 diabetic patients, no microalbuminuria, no hypertension</p> </li> <li> <p>Number: treatment group (43); control group (46)</p> </li> <li> <p>Mean age ± SD (years): treatment group (44 ± 14); control group (46 ± 13)</p> </li> <li> <p>Males (%): treatment group (55); control group (58)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0111"> <li> <p>Ongoing treatment with ACEi; know side‐effects of ACEi; pregnancy or intended pregnancy; known kidney disease; systolic BP &lt; 100 mm Hg or diastolic BP &lt; 50 mm Hg </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0112"> <li> <p>Perindopril: 2 mg x 2/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0113"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0114"> <li> <p>Changes in albuminuria</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0115"> <li> <p>Additional outcome data obtained from author</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'double‐blind'</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11/89 patients drop out due to non‐compliance</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported all outcomes specified in the methods</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Lin 1995 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0116"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up: 12 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0117"> <li> <p>Setting: university</p> </li> <li> <p>Country: USA</p> </li> <li> <p>All type 2 diabetes, proportion with normoalbuminuria, microalbuminuria or macroalbuminuria not available; all hypertensive </p> </li> <li> <p>Number: treatment group 1 (20); treatment group 2 (20); control group (20)</p> </li> <li> <p>Mean age ± SD (years): treatment group 1 (62 ± 7); treatment group 2 (63 ± 7); control group (62 ± 8) </p> </li> <li> <p>Sex (M/F): only males</p> </li> </ul> </p> <p>Exclusion criteria: not stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group 1</p> <p> <ul id="CD004136-lst1-0118"> <li> <p>Captopril: 25‐150 mg/d</p> </li> </ul> </p> <p>Treatment group 2</p> <p> <ul id="CD004136-lst1-0119"> <li> <p>Enalapril: 5‐40 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0120"> <li> <p>Conventional treatment</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0121"> <li> <p>BP</p> </li> <li> <p>Proteinuria</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0122"> <li> <p>Additional outcome data obtained from author</p> </li> <li> <p>BP target equalization achieved in study by use of other antihypertensive co‐interventions</p> </li> <li> <p>End of treatment HbA1c: treatment groups (7.0%); control group (7.6%)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomisation order was arranged by computer setting</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open‐label design</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Albuminuria change was not reported in detail for the data to be included in a meta‐analysis</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">ONTARGET Study 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0123"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Recruitment: November 2001 to June 2004</p> </li> <li> <p>Follow‐up duration: 56 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0124"> <li> <p>Setting: multicentre study (730 centres)</p> </li> <li> <p>Countries: 40 countries</p> </li> <li> <p>Type 1 and type 2 diabetes (37.5%); normoalbuminuria (4414); 86.2% hypertensive</p> </li> <li> <p>Number: treatment group (8576); control group 1 (8542); control group 2 (8502)</p> </li> <li> <p>Mean age ± SD (years): treatment group (66.4 ± 7.2); control group 1 (66.4 ± 7.1); control group 2 (66.5 ± 7.3) </p> </li> <li> <p>Sex (M/F): treatment group (6245/2331); control group 1 (6292/2250); control group 2 (6252/2250) </p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0125"> <li> <p>Major renal artery stenosis; uncorrected volume or sodium depletion; a SCr &gt; 265 μmol/L; uncontrolled hypertension (&gt; 160 mm Hg systolic or &gt; 100 mm Hg diastolic) </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0126"> <li> <p>Ramipril: 10 mg/d</p> </li> </ul> </p> <p>Control group 1</p> <p> <ul id="CD004136-lst1-0127"> <li> <p>Telmisartan: 80 mg/d</p> </li> </ul> </p> <p>Control group 2</p> <p> <ul id="CD004136-lst1-0128"> <li> <p>Combination of ramipril and telmisartan</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0129"> <li> <p>Death</p> </li> <li> <p>Cardiovascular death</p> </li> <li> <p>ESKD</p> </li> <li> <p>Doubling of SCr</p> </li> <li> <p>Onset of microalbuminuria</p> </li> <li> <p>Toxicity</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0130"> <li> <p>Additional outcome data obtained from author</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'randomisation was stratified according to site with the use of permuted blocks'</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'randomised via a computerized voice‐activated telephone call to a central office"</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blind design</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.2% of the participants were missing</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All outcomes described in the protocol were reported</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Perrin 2008 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0131"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up duration: 60 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0132"> <li> <p>Setting: single centre</p> </li> <li> <p>Country: Sweden</p> </li> <li> <p>Diabetic subjects with normoalbuminuria; all type 1 diabetes; all normotensive</p> </li> <li> <p>Number: treatment group (7); control group (6)</p> </li> <li> <p>Age (range): treatment group (23 years, 20–26); control group (24 years, 24–26)</p> </li> <li> <p>Sex (M/F): treatment group (2/7); control group (4/6)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0133"> <li> <p>Pregnancy or no reliable anti‐conception treatment; microalbuminuria; hypertension; severely reduced kidney or liver function; ongoing antihypertensive treatment </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0134"> <li> <p>Candesartan: 16 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0135"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0136"> <li> <p>New onset albuminuria</p> </li> <li> <p>BP</p> </li> <li> <p>GFR</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0137"> <li> <p>End of treatment HbA1c: treatment group (7.8%); control group (.7.7%)</p> </li> <li> <p>The study was sponsored by Astra Zeneca, and was also supported by a grant from the Swedish Medical Research Council (no. 6864) </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blind design. The pills could not be distinguished by patients or medical or pharmacy personnel </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3/13 patients missing from the study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported all outcomes specified in the methods</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">RASS Study 2002 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0138"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up duration: 60 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0139"> <li> <p>Country: Canada, USA</p> </li> <li> <p>Setting: multicentre (3)</p> </li> <li> <p>Diabetic subjects with normoalbuminuria; all type 1 diabetes; all normotensive</p> </li> <li> <p>Number: treatment group (94); treatment group 2 (96); control group (95)</p> </li> <li> <p>Meand age ± SD (years): treatment group 1 (30.6 ± 10.0); treatment group 2 (29.3 ± 10.2); control group (29.1 ± 9.1) </p> </li> <li> <p>Sex (M/F): treatment group 1 (48/46); treatment group 2 (46/50); control group (45/50)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0140"> <li> <p>Hypertension or receipt of antihypertensive medications; albumin excretion rate &gt; 20 μg/min; pregnancy; failure to take at least 85% of placebo pills during a 2‐week run‐in period; GFR &lt; 90 mL/min/1.73 m² (&lt; 80 mL/min if the patient had a strictly vegan diet) </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group 1</p> <p> <ul id="CD004136-lst1-0141"> <li> <p>Enalapril: 10‐20 mg/d</p> </li> </ul> </p> <p>Treatment group 2</p> <p> <ul id="CD004136-lst1-0142"> <li> <p>Losartan: 50‐100 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0143"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0144"> <li> <p>Death</p> </li> <li> <p>ESKD</p> </li> <li> <p>Doubling of SCr</p> </li> <li> <p>New onset of microalbuminuria</p> </li> <li> <p>Toxicity</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0145"> <li> <p>Additional outcome data obtained from author</p> </li> <li> <p>No difference in end of treatment HbA1c values</p> </li> <li> <p>'Supported by research grants from the National Institutes of Health (NIH), the National Institute of Diabetes and Digestive and Kidney Diseases (DK51975), Merck (in the United States),Merck Frosst (in Canada), and the Canadian Institutes of Health Research (CIHR) (DCT 14281). RASS was supported in part by a grant from the National Center for Research Resources of the NIH, to the University of Minnesota General Clinical Research Center (GCRC) (M01‐RR00400)' </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Computer‐generated blocks of six, stratification by centre</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blind design</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>All measurements were performed by one observer, who was unaware of the study‐drug assignments </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>256/285 (90%) had baseline and 5 year biopsies; 223/285 (78%) had baseline and 5 year retinopathy </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported all outcomes described in the protocol</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ravid 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0146"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up: 72 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0147"> <li> <p>Setting: multicentre (8 clinics)</p> </li> <li> <p>Country: Israel</p> </li> <li> <p>Diabetic subjects with normoalbuminuria; all type 2 diabetes; all hypertensive</p> </li> <li> <p>Number: treatment group (97); control group (97)</p> </li> <li> <p>Mean age ± SD (years): treatment group (55.5 ± 3.1); control group (54.4 ± 2.9)</p> </li> <li> <p>Sex (M/F): treatment group (37/40); control group (38/41)</p> </li> </ul> </p> <p>Exclusion criteria: not stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0148"> <li> <p>Enalapril: 5‐10 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0149"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0150"> <li> <p>Death</p> </li> <li> <p>Cardiovascular death</p> </li> <li> <p>Cough</p> </li> <li> <p>Hyperkalaemia</p> </li> <li> <p>Development of albuminuria</p> </li> <li> <p>Mean arterial pressure</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0151"> <li> <p>Additional outcome data obtained from author</p> </li> <li> <p>BP target equalisation achieved in study by use of other antihypertensive co‐interventions</p> </li> <li> <p>End of treatment HbA1c: treatment group (8.7%); control group (8.5%)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random number table</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomisation was done centrally by telephone</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blind design</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16/97 missing from intervention group; 17/97 missing from control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported all outcomes described in the methods</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">ROADMAP Study 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0152"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Recruitment: October 2004 to May 2006</p> </li> <li> <p>Follow‐up: 38.4 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0153"> <li> <p>Setting: international multicentre (262 centres)</p> </li> <li> <p>Country: 19 European countries</p> </li> <li> <p>Diabetic subjects with normoalbuminuria; all type 2 diabetes; 90.3% hypertensive</p> </li> <li> <p>Number: treatment group (2233); control group (2216)</p> </li> <li> <p>Mean age ± SD (years): treatment group (57.7 ± 8.8); control group (57.8 ± 8.6)</p> </li> <li> <p>Sex (M/F): treatment group (1049/1184); control group (1003/1213)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0154"> <li> <p>ACEi or ARB during the 6 months before the start of the study</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0155"> <li> <p>Olmesartan: 40 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0156"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0157"> <li> <p>Death</p> </li> <li> <p>Cardiovascular death</p> </li> <li> <p>ESKD</p> </li> <li> <p>Doubling SCr</p> </li> <li> <p>Development of albuminuria</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0158"> <li> <p>BP target equalisation achieved in study by use of other antihypertensive co‐interventions</p> </li> <li> <p>'The sponsor (Daiichi Sankyo) had no role in the design or conduct of the study, but representatives of the sponsor served as nonvoting members of the steering committee' </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Randomisation list produced by PRA using SAS software</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sealed envelopes used in randomisation allocation</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blind design</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51/2233 lost from intervention group; 57/2216 lost from control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported all outcomes described in the protocol</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Scognamiglio 1997 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0159"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up period: 36 weeks</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0160"> <li> <p>Setting: not described</p> </li> <li> <p>Country: Italy</p> </li> <li> <p>Diabetic subjects with normoalbuminuria; all type 1 diabetes; all hypertensive</p> </li> <li> <p>Number: treatment group (36); control group (37)</p> </li> <li> <p>Mean age ± SD (years): treatment group (58.7 ± 6.9); control group (57.3 ± 6.7)</p> </li> <li> <p>Sex (M/F): treatment group (26/10); control group (29/8)</p> </li> </ul> </p> <p>Exclusion criteria: not stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0161"> <li> <p>Captopril: 50‐100 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0162"> <li> <p>Nitrendipine: 20‐40 mg/d</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0163"> <li> <p>Death</p> </li> <li> <p>ESKD</p> </li> <li> <p>BP</p> </li> <li> <p>Albuminuria</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0164"> <li> <p>End of treatment HbA1c: treatment group (6.0%); control group (6.8%)</p> </li> <li> <p>BP target equalisation not achieved in study (no use of other antihypertensive co‐interventions)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open‐label design</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3/73 patients dropped out</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Albuminuria was not reported in enough detail for the data to be included in the meta‐analyses</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">TRANSCEND Study 2009 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0165"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Recruitment: November 2001 to May 2004</p> </li> <li> <p>Follow‐up duration: 56 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0166"> <li> <p>Setting: international multicentre (630 centres)</p> </li> <li> <p>Country: 40 countries</p> </li> <li> <p>Diabetic subjects with normoalbuminuria; type 1 and type 2 diabetes; 89% hypertensive</p> </li> <li> <p>Treatment group</p> </li> <li> <p>Number: treatment group (2954); control group (2972)</p> </li> <li> <p>Mean age ± SD (years): treatment group (66.9 ± 7.3); control group (66.9 ± 7.4)</p> </li> <li> <p>Sex (M/F): treatment group (1674/1280); control group (1705/1267)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0167"> <li> <p>Needed an ARB; hypersensitive or intolerant to ARB; heart failure, significant valvular or cardiac outflow tract obstruction, constrictive pericarditis complex congenital heart disease, unexplained syncope, planned cardiac surgery, cardiac revascularization in the previous 3 months; systolic BP ≥ 160 mm Hg; heart transplantation; subarachnoid haemorrhage; known significant renal artery stenosis; SCr levels &gt; 265 mol/L (3.0 mg/dL); hepatic dysfunction. </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0168"> <li> <p>Telmisartan: 80 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0169"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0170"> <li> <p>Death</p> </li> <li> <p>Cardiovascular death</p> </li> <li> <p>ESKD</p> </li> <li> <p>Doubling of SCr</p> </li> <li> <p>Onset of microalbuminuria</p> </li> <li> <p>Toxicity</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0171"> <li> <p>Additional outcome data obtained from author</p> </li> <li> <p>'Boehringer Ingelheim funded the study. The steering committee designed and oversaw the study and had the final decision on the contents of the manuscript. All data were received, checked, and analyzed independently at the coordinating center at McMaster University.' </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'randomisation was stratified according to site with the use of permuted blocks'</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>randomised via a computerized voice‐activated telephone call</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blind design 'All participants and trial investigators were blinded to randomized treatment' </p> <p>'Unblinded data were made available exclusively to the independent data safety and monitoring board by a statistician who was independent of the trial' </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10/2954 lost from intervention group; 8/2972 lost from control group</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reportes all outcomes in the protocol</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Tuominen 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0172"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up period: 24 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0173"> <li> <p>Setting: Teaching hospital</p> </li> <li> <p>Country: Finland</p> </li> <li> <p>Diabetic subjects with normoalbuminuria; all type 1 diabetes; all normotensive</p> </li> <li> <p>Number: treatment group (13); control group (13)</p> </li> <li> <p>Mean age ± SD (years): treatment group (34.0 ± 7.2); control group (36 ± 10)</p> </li> <li> <p>Sex (M/F): overall (14/12)</p> </li> </ul> </p> <p>Exclusion criteria: not stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0174"> <li> <p>Lisinopril: 15‐20 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0175"> <li> <p>Placebo</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0176"> <li> <p>BP</p> </li> <li> <p>Onset of microalbuminuria</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0177"> <li> <p>Additional outcome data obtained from author</p> </li> <li> <p>End of treatment HbA1c not available</p> </li> <li> <p>BP target equalisation not achieved in study (no use of other antihypertensive co‐interventions)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blind design</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Two patients discontinued the study (both in the lisinopril group) because of pregnancy and a wish to become pregnant </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reporting all outcomes described in the methods</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">UKPDS Study 1998 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0178"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up period: 48 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0179"> <li> <p>Setting: multicentre</p> </li> <li> <p>Country: UK</p> </li> <li> <p>Proportion with normoalbuminuria, microalbuminuria or macroalbuminuria not available; all type 2 diabetes; all hypertensive </p> </li> <li> <p>Number: treatment group (758); control group (390)</p> </li> <li> <p>Mean age SD (years): treatment group (56.3 ± 8.1); control group (56.0 ± 8.2)</p> </li> <li> <p>Sex (M/F): treatment group (205/195); control group (205/153)</p> </li> </ul> </p> <p>Exclusion criteria</p> <p> <ul id="CD004136-lst1-0180"> <li> <p>Clinical requirement for strict BP control or beta blockade; severe vascular disease; a severe concurrent illness or contraindications to beta blockers; pregnancy; or unwilling­ness to join the study </p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0181"> <li> <p>Captopril: 25‐50 mg x 2/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0182"> <li> <p>Atenolol: 50‐100 mg/d</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0183"> <li> <p>Death</p> </li> <li> <p>Onset of micro or macroalbuminuria</p> </li> <li> <p>BP</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0184"> <li> <p>BP target equalization achieved in study (use of other antihypertensive co‐interventions)</p> </li> <li> <p>End of treatment HbA1c: treatment group (8.3%); control group (8.%)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>'Randomisation stratified for those with or without previous treatment for hypertension was performed by the coordinating centre' </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Sealed opaque envelopes were used</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Open label study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Copies of endpoint information, without reference to the patient's allocated or actual treatment, were formally presented to two independent physicians </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4% participants were lost follow‐up</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported outcomes described in the protocol</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Velussi 1996 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0185"> <li> <p>Study design: parallel RCT</p> </li> <li> <p>Follow‐up period: 24 months</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Inclusion criteria</p> <p> <ul id="CD004136-lst1-0186"> <li> <p>Setting: university</p> </li> <li> <p>Country: Italy</p> </li> <li> <p>Normoalbuminuria (29), microalbuminuria (21); all type 2 diabetes; all hypertensive</p> </li> <li> <p>Number: overall (50)</p> </li> <li> <p>Age: unclear</p> </li> <li> <p>Sex (M/F): not stated</p> </li> </ul> </p> <p>Exclusion criteria: not stated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>Treatment group</p> <p> <ul id="CD004136-lst1-0187"> <li> <p>Cilazapril: 2.5 mg/d</p> </li> </ul> </p> <p>Control group</p> <p> <ul id="CD004136-lst1-0188"> <li> <p>Amlodipine: 5 mg/d</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0189"> <li> <p>BP</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p> <ul id="CD004136-lst1-0190"> <li> <p>Additional outcome data obtained from author</p> </li> <li> <p>BP target equalisation achieved in study (use of other antihypertensive co‐interventions)</p> </li> <li> <p>End of treatment HbA1c: treatment group (8.0%); control group (8.0%)</p> </li> </ul> </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Random sequence generation (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment (selection bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of participants and personnel (performance bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Double‐blinded double‐dummy design</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Blinding of outcome assessment (detection bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not described</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Incomplete outcome data (attrition bias) <br> All outcomes </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>High risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6/50(12%) participants missing from the study</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Selective reporting (reporting bias)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reported all outcomes described in the methods</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ACEi ‐ angiotensin‐converting enzyme inhibitor; ARB ‐ angiotensin receptor blockers; BP ‐ blood pressure; DKD ‐ diabetic kidney disease; ESKD ‐ end‐stage kidney disease; SCr ‐ serum creatinine </p> </div> </div> </p> </section> <section class="characteristicsOfExcludedStudies" lang=""> <div class="section-header" id="CD004136-sec2-0020"> <h3 class="title">Characteristics of excluded studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD004136-sec2-0019" class="jump-to">included studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reason for exclusion</p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD004136-bbs2-0027">ALLHAT 2002</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Baseline data on kidney disease were not available, so that we were not able to separate out the data of diabetic patients with normoalbuminuria and could not include these data in our main analyses </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD004136-bbs2-0028">CAPPP 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Baseline data on kidney disease were not available, so that we were not able to separate out the data of diabetic patients with normoalbuminuria and could not include these data in our main analyses </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD004136-bbs2-0029">Hansson 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Baseline data on kidney disease were not available, so that we were not able to separate out the data of diabetic patients with normoalbuminuria and could not include these data in our main analyses </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD004136-bbs2-0030">HOT 1998</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Baseline data on kidney disease were not available, so that we were not able to separate out the data of diabetic patients with normoalbuminuria and could not include these data in our main analyses </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD004136-bbs2-0031">INSIGHT 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Baseline data on kidney disease were not available, so that we were not able to separate out the data of diabetic patients with normoalbuminuria and could not include these data in our main analyses </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD004136-bbs2-0032">NORDIL 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Baseline data on kidney disease were not available, so that we were not able to separate out the data of diabetic patients with normoalbuminuria and could not include these data in our main analyses </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD004136-bbs2-0033">Tuomilehto 1999</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Baseline data on kidney disease were not available, so that we were not able to separate out the data of diabetic patients with normoalbuminuria and could not include these data in our main analyses </p> </td> </tr> </tbody> </table> </div> </p> </section> </section> <section class="dataAndAnalyses" id="dataAndAnalyses"> <section class="dataAndAnalyses" lang="en"> <div class="section-header section-collapse-header" id="CD004136-sec1-0010"> <h2 class="title section-collapse-title">Data and analyses<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <div class="table" id="CD004136-tbl-0001"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">ACEi versus placebo/no treatment</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Normo‐ to micro‐ or macroalbuminuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11906</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.71 [0.56, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-001-01.png?filename=nCD004136-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20ACEi%20versus%20placebo%2Fno%20treatment%2C%20Outcome%201%20Normo%E2%80%90%20to%20micro%E2%80%90%20or%20macroalbuminuria.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.1</div> </div> <hr class="top"><img data-id="CD004136-fig-00101" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-01.png" alt="Comparison 1 ACEi versus placebo/no treatment, Outcome 1 Normo‐ to micro‐ or macroalbuminuria."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 ACEi versus placebo/no treatment, Outcome 1 Normo‐ to micro‐ or macroalbuminuria.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11350</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.84 [0.73, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00102"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-001-02.png?filename=nCD004136-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20ACEi%20versus%20placebo%2Fno%20treatment%2C%20Outcome%202%20All%E2%80%90cause%20mortality.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.2</div> </div> <hr class="top"><img data-id="CD004136-fig-00102" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-02.png" alt="Comparison 1 ACEi versus placebo/no treatment, Outcome 2 All‐cause mortality."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 ACEi versus placebo/no treatment, Outcome 2 All‐cause mortality.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Doubling of SCr <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10749</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 [0.39, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00103"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-001-03.png?filename=nCD004136-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20ACEi%20versus%20placebo%2Fno%20treatment%2C%20Outcome%203%20Doubling%20of%20SCr.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.3</div> </div> <hr class="top"><img data-id="CD004136-fig-00103" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-03.png" alt="Comparison 1 ACEi versus placebo/no treatment, Outcome 3 Doubling of SCr."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 ACEi versus placebo/no treatment, Outcome 3 Doubling of SCr.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 ESKD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10504</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.94 [0.66, 5.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00104"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-001-04.png?filename=nCD004136-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20ACEi%20versus%20placebo%2Fno%20treatment%2C%20Outcome%204%20ESKD.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.4</div> </div> <hr class="top"><img data-id="CD004136-fig-00104" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-04.png" alt="Comparison 1 ACEi versus placebo/no treatment, Outcome 4 ESKD."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 ACEi versus placebo/no treatment, Outcome 4 ESKD.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00105"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-001-05.png?filename=nCD004136-CMP-001-05.ppt&amp;title=1.5&amp;caption=Comparison%201%20ACEi%20versus%20placebo%2Fno%20treatment%2C%20Outcome%205%20Adverse%20events.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.5</div> </div> <hr class="top"><img data-id="CD004136-fig-00105" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-05.png" alt="Comparison 1 ACEi versus placebo/no treatment, Outcome 5 Adverse events."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 ACEi versus placebo/no treatment, Outcome 5 Adverse events.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Cough</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11791</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.84 [1.24, 2.72]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 Headache</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10504</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.19 [0.47, 3.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.3 Hyperkalaemia</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2783</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.98 [0.47, 18.78]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00106"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-001-06.png?filename=nCD004136-CMP-001-06.ppt&amp;title=1.6&amp;caption=Comparison%201%20ACEi%20versus%20placebo%2Fno%20treatment%2C%20Outcome%206%20Blood%20pressure.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.6</div> </div> <hr class="top"><img data-id="CD004136-fig-00106" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-06.png" alt="Comparison 1 ACEi versus placebo/no treatment, Outcome 6 Blood pressure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 ACEi versus placebo/no treatment, Outcome 6 Blood pressure.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.1 Systolic BP</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7526</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐5.37 [‐7.12, ‐3.62]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.2 Diastolic BP</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7526</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.50 [‐1.50, ‐1.50]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD004136-tbl-0002"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">ARB versus placebo/no treatment</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Normo‐ to micro‐ or macroalbuminuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7653</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.90 [0.68, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00201"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-002-01.png?filename=nCD004136-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20ARB%20versus%20placebo%2Fno%20treatment%2C%20Outcome%201%20Normo%E2%80%90%20to%20micro%E2%80%90%20or%20macroalbuminuria.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.1</div> </div> <hr class="top"><img data-id="CD004136-fig-00201" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-01.png" alt="Comparison 2 ARB versus placebo/no treatment, Outcome 1 Normo‐ to micro‐ or macroalbuminuria."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 ARB versus placebo/no treatment, Outcome 1 Normo‐ to micro‐ or macroalbuminuria.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7653</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.12 [0.88, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00202"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-002-02.png?filename=nCD004136-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20ARB%20versus%20placebo%2Fno%20treatment%2C%20Outcome%202%20All%E2%80%90cause%20mortality.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.2</div> </div> <hr class="top"><img data-id="CD004136-fig-00202" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-02.png" alt="Comparison 2 ARB versus placebo/no treatment, Outcome 2 All‐cause mortality."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 ARB versus placebo/no treatment, Outcome 2 All‐cause mortality.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Doubling of SCr <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6217</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.36 [0.64, 2.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00203"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-002-03.png?filename=nCD004136-CMP-002-03.ppt&amp;title=2.3&amp;caption=Comparison%202%20ARB%20versus%20placebo%2Fno%20treatment%2C%20Outcome%203%20Doubling%20of%20SCr.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.3</div> </div> <hr class="top"><img data-id="CD004136-fig-00203" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-03.png" alt="Comparison 2 ARB versus placebo/no treatment, Outcome 3 Doubling of SCr."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 ARB versus placebo/no treatment, Outcome 3 Doubling of SCr.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 ESKD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6217</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.50 [0.09, 2.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00204"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-002-04.png?filename=nCD004136-CMP-002-04.ppt&amp;title=2.4&amp;caption=Comparison%202%20ARB%20versus%20placebo%2Fno%20treatment%2C%20Outcome%204%20ESKD.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.4</div> </div> <hr class="top"><img data-id="CD004136-fig-00204" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-04.png" alt="Comparison 2 ARB versus placebo/no treatment, Outcome 4 ESKD."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 ARB versus placebo/no treatment, Outcome 4 ESKD.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00205"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-002-05.png?filename=nCD004136-CMP-002-05.ppt&amp;title=2.5&amp;caption=Comparison%202%20ARB%20versus%20placebo%2Fno%20treatment%2C%20Outcome%205%20Adverse%20events.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.5</div> </div> <hr class="top"><img data-id="CD004136-fig-00205" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-05.png" alt="Comparison 2 ARB versus placebo/no treatment, Outcome 5 Adverse events."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 ARB versus placebo/no treatment, Outcome 5 Adverse events.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Cough</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1770</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.01 [0.42, 2.44]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 Headache</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3191</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.52, 1.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.3 Hyperkalaemia</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3191</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.30 [0.69, 7.71]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00206"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-002-06.png?filename=nCD004136-CMP-002-06.ppt&amp;title=2.6&amp;caption=Comparison%202%20ARB%20versus%20placebo%2Fno%20treatment%2C%20Outcome%206%20Blood%20pressure.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.6</div> </div> <hr class="top"><img data-id="CD004136-fig-00206" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-06.png" alt="Comparison 2 ARB versus placebo/no treatment, Outcome 6 Blood pressure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 ARB versus placebo/no treatment, Outcome 6 Blood pressure.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.1 Systolic BP</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1770</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐3.28 [‐5.29, ‐1.27]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.2 Diastolic BP</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1770</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.0 [‐2.64, ‐1.36]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD004136-tbl-0003"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">ACEi versus ARB</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Normo‐ to micro‐ or macroalbuminuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4303</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.57 [0.14, 2.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00301"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-003-01.png?filename=nCD004136-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20ACEi%20versus%20ARB%2C%20Outcome%201%20Normo%E2%80%90%20to%20micro%E2%80%90%20or%20macroalbuminuria.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.1</div> </div> <hr class="top"><img data-id="CD004136-fig-00301" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-003-01.png" alt="Comparison 3 ACEi versus ARB, Outcome 1 Normo‐ to micro‐ or macroalbuminuria."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 ACEi versus ARB, Outcome 1 Normo‐ to micro‐ or macroalbuminuria.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4303</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.02 [0.85, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00302"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-003-02.png?filename=nCD004136-CMP-003-02.ppt&amp;title=3.2&amp;caption=Comparison%203%20ACEi%20versus%20ARB%2C%20Outcome%202%20All%E2%80%90cause%20mortality.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.2</div> </div> <hr class="top"><img data-id="CD004136-fig-00302" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-003-02.png" alt="Comparison 3 ACEi versus ARB, Outcome 2 All‐cause mortality."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 ACEi versus ARB, Outcome 2 All‐cause mortality.</p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD004136-tbl-0004"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">ACEi versus CCB</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Normo to micro or macroalbuminuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1253</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.60 [0.42, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00401"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-004-01.png?filename=nCD004136-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20ACEi%20versus%20CCB%2C%20Outcome%201%20Normo%20to%20micro%20or%20macroalbuminuria.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.1</div> </div> <hr class="top"><img data-id="CD004136-fig-00401" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-01.png" alt="Comparison 4 ACEi versus CCB, Outcome 1 Normo to micro or macroalbuminuria."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 ACEi versus CCB, Outcome 1 Normo to micro or macroalbuminuria.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1519</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.84 [0.26, 2.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00402"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-004-02.png?filename=nCD004136-CMP-004-02.ppt&amp;title=4.2&amp;caption=Comparison%204%20ACEi%20versus%20CCB%2C%20Outcome%202%20All%E2%80%90cause%20mortality.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.2</div> </div> <hr class="top"><img data-id="CD004136-fig-00402" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-02.png" alt="Comparison 4 ACEi versus CCB, Outcome 2 All‐cause mortality."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 ACEi versus CCB, Outcome 2 All‐cause mortality.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Doubling of SCr <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>607</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00403"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-004-03.png?filename=nCD004136-CMP-004-03.ppt&amp;title=4.3&amp;caption=Comparison%204%20ACEi%20versus%20CCB%2C%20Outcome%203%20Doubling%20of%20SCr.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.3</div> </div> <hr class="top"><img data-id="CD004136-fig-00403" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-03.png" alt="Comparison 4 ACEi versus CCB, Outcome 3 Doubling of SCr."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 ACEi versus CCB, Outcome 3 Doubling of SCr.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 ESKD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>680</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00404"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-004-04.png?filename=nCD004136-CMP-004-04.ppt&amp;title=4.4&amp;caption=Comparison%204%20ACEi%20versus%20CCB%2C%20Outcome%204%20ESKD.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.4</div> </div> <hr class="top"><img data-id="CD004136-fig-00404" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-04.png" alt="Comparison 4 ACEi versus CCB, Outcome 4 ESKD."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 ACEi versus CCB, Outcome 4 ESKD.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00405"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-004-05.png?filename=nCD004136-CMP-004-05.ppt&amp;title=4.5&amp;caption=Comparison%204%20ACEi%20versus%20CCB%2C%20Outcome%205%20Blood%20pressure.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.5</div> </div> <hr class="top"><img data-id="CD004136-fig-00405" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-05.png" alt="Comparison 4 ACEi versus CCB, Outcome 5 Blood pressure."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 ACEi versus CCB, Outcome 5 Blood pressure.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Systolic BP</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>430</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.0 [1.59, 6.41]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 Diastolic BP</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>430</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.22 [‐0.42, 2.85]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD004136-tbl-0005"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">Prevention of kidney disease: other agents</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 ACEi + ARB versus ACEi <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4171</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.88 [0.78, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00501"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-005-01.png?filename=nCD004136-CMP-005-01.ppt&amp;title=5.1&amp;caption=Comparison%205%20Prevention%20of%20kidney%20disease%3A%20other%20agents%2C%20Outcome%201%20ACEi%20%2B%20ARB%20versus%20ACEi.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 5.1</div> </div> <hr class="top"><img data-id="CD004136-fig-00501" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-005-01.png" alt="Comparison 5 Prevention of kidney disease: other agents, Outcome 1 ACEi + ARB versus ACEi."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 5 Prevention of kidney disease: other agents, Outcome 1 ACEi + ARB versus ACEi. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 ACEi versus BB <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00502"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-005-02.png?filename=nCD004136-CMP-005-02.ppt&amp;title=5.2&amp;caption=Comparison%205%20Prevention%20of%20kidney%20disease%3A%20other%20agents%2C%20Outcome%202%20ACEi%20versus%20BB.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 5.2</div> </div> <hr class="top"><img data-id="CD004136-fig-00502" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-005-02.png" alt="Comparison 5 Prevention of kidney disease: other agents, Outcome 2 ACEi versus BB."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 5 Prevention of kidney disease: other agents, Outcome 2 ACEi versus BB.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 ACEi + CCB versus ACEi <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00503"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-005-03.png?filename=nCD004136-CMP-005-03.ppt&amp;title=5.3&amp;caption=Comparison%205%20Prevention%20of%20kidney%20disease%3A%20other%20agents%2C%20Outcome%203%20ACEi%20%2B%20CCB%20versus%20ACEi.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 5.3</div> </div> <hr class="top"><img data-id="CD004136-fig-00503" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-005-03.png" alt="Comparison 5 Prevention of kidney disease: other agents, Outcome 3 ACEi + CCB versus ACEi."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 5 Prevention of kidney disease: other agents, Outcome 3 ACEi + CCB versus ACEi. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 CCB versus placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD004136-fig-00504"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-005-04.png?filename=nCD004136-CMP-005-04.ppt&amp;title=5.4&amp;caption=Comparison%205%20Prevention%20of%20kidney%20disease%3A%20other%20agents%2C%20Outcome%204%20CCB%20versus%20placebo.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 5.4</div> </div> <hr class="top"><img data-id="CD004136-fig-00504" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-005-04.png" alt="Comparison 5 Prevention of kidney disease: other agents, Outcome 4 CCB versus placebo."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 5 Prevention of kidney disease: other agents, Outcome 4 CCB versus placebo.</p> </div> </div> </div> </td> </tr> </tbody> </table> </div> </section> </section> <div class="figures-list"> <div class="figure" id="CD004136-fig-0001"> <img data-id="CD004136-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-AFig-FIG01.png" alt="Study flow diagram."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full#CD004136-fig-0001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-AFig-FIG01.png?filename=nCD004136-AFig-FIG01.ppt&amp;title=1&amp;caption=Study%20flow%20diagram.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-AFig-FIG01.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-0002"><img data-id="CD004136-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-AFig-FIG02.png" alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full#CD004136-fig-0002" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-AFig-FIG02.png?filename=nCD004136-AFig-FIG02.ppt&amp;title=2&amp;caption=Risk%20of%20bias%20graph%3A%20review%20authors%27%20judgements%20about%20each%20risk%20of%20bias%20item%20presented%20as%20percentages%20across%20all%20included%20studies.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-AFig-FIG02.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-0003"><img data-id="CD004136-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-AFig-FIG03.png" alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full#CD004136-fig-0003" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-AFig-FIG03.png?filename=nCD004136-AFig-FIG03.ppt&amp;title=3&amp;caption=Risk%20of%20bias%20summary%3A%20review%20authors%27%20judgements%20about%20each%20risk%20of%20bias%20item%20for%20each%20included%20study.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-AFig-FIG03.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00101"><img data-id="CD004136-fig-00101" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-01.png" alt="Comparison 1 ACEi versus placebo/no treatment, Outcome 1 Normo‐ to micro‐ or macroalbuminuria."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 ACEi versus placebo/no treatment, Outcome 1 Normo‐ to micro‐ or macroalbuminuria.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-001-01.png?filename=nCD004136-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20ACEi%20versus%20placebo%2Fno%20treatment%2C%20Outcome%201%20Normo%E2%80%90%20to%20micro%E2%80%90%20or%20macroalbuminuria.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00102"><img data-id="CD004136-fig-00102" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-02.png" alt="Comparison 1 ACEi versus placebo/no treatment, Outcome 2 All‐cause mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 ACEi versus placebo/no treatment, Outcome 2 All‐cause mortality.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00102" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-001-02.png?filename=nCD004136-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20ACEi%20versus%20placebo%2Fno%20treatment%2C%20Outcome%202%20All%E2%80%90cause%20mortality.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00103"><img data-id="CD004136-fig-00103" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-03.png" alt="Comparison 1 ACEi versus placebo/no treatment, Outcome 3 Doubling of SCr."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 ACEi versus placebo/no treatment, Outcome 3 Doubling of SCr.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00103" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-001-03.png?filename=nCD004136-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20ACEi%20versus%20placebo%2Fno%20treatment%2C%20Outcome%203%20Doubling%20of%20SCr.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00104"><img data-id="CD004136-fig-00104" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-04.png" alt="Comparison 1 ACEi versus placebo/no treatment, Outcome 4 ESKD."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 ACEi versus placebo/no treatment, Outcome 4 ESKD.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00104" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-001-04.png?filename=nCD004136-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20ACEi%20versus%20placebo%2Fno%20treatment%2C%20Outcome%204%20ESKD.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00105"><img data-id="CD004136-fig-00105" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-05.png" alt="Comparison 1 ACEi versus placebo/no treatment, Outcome 5 Adverse events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 ACEi versus placebo/no treatment, Outcome 5 Adverse events.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00105" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-001-05.png?filename=nCD004136-CMP-001-05.ppt&amp;title=1.5&amp;caption=Comparison%201%20ACEi%20versus%20placebo%2Fno%20treatment%2C%20Outcome%205%20Adverse%20events.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00106"><img data-id="CD004136-fig-00106" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-06.png" alt="Comparison 1 ACEi versus placebo/no treatment, Outcome 6 Blood pressure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 ACEi versus placebo/no treatment, Outcome 6 Blood pressure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00106" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-001-06.png?filename=nCD004136-CMP-001-06.ppt&amp;title=1.6&amp;caption=Comparison%201%20ACEi%20versus%20placebo%2Fno%20treatment%2C%20Outcome%206%20Blood%20pressure.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-001-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00201"><img data-id="CD004136-fig-00201" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-01.png" alt="Comparison 2 ARB versus placebo/no treatment, Outcome 1 Normo‐ to micro‐ or macroalbuminuria."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 ARB versus placebo/no treatment, Outcome 1 Normo‐ to micro‐ or macroalbuminuria.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00201" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-002-01.png?filename=nCD004136-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20ARB%20versus%20placebo%2Fno%20treatment%2C%20Outcome%201%20Normo%E2%80%90%20to%20micro%E2%80%90%20or%20macroalbuminuria.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00202"><img data-id="CD004136-fig-00202" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-02.png" alt="Comparison 2 ARB versus placebo/no treatment, Outcome 2 All‐cause mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 ARB versus placebo/no treatment, Outcome 2 All‐cause mortality.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00202" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-002-02.png?filename=nCD004136-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20ARB%20versus%20placebo%2Fno%20treatment%2C%20Outcome%202%20All%E2%80%90cause%20mortality.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00203"><img data-id="CD004136-fig-00203" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-03.png" alt="Comparison 2 ARB versus placebo/no treatment, Outcome 3 Doubling of SCr."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 ARB versus placebo/no treatment, Outcome 3 Doubling of SCr.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00203" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-002-03.png?filename=nCD004136-CMP-002-03.ppt&amp;title=2.3&amp;caption=Comparison%202%20ARB%20versus%20placebo%2Fno%20treatment%2C%20Outcome%203%20Doubling%20of%20SCr.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00204"><img data-id="CD004136-fig-00204" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-04.png" alt="Comparison 2 ARB versus placebo/no treatment, Outcome 4 ESKD."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 ARB versus placebo/no treatment, Outcome 4 ESKD.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00204" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-002-04.png?filename=nCD004136-CMP-002-04.ppt&amp;title=2.4&amp;caption=Comparison%202%20ARB%20versus%20placebo%2Fno%20treatment%2C%20Outcome%204%20ESKD.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00205"><img data-id="CD004136-fig-00205" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-05.png" alt="Comparison 2 ARB versus placebo/no treatment, Outcome 5 Adverse events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 ARB versus placebo/no treatment, Outcome 5 Adverse events.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00205" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-002-05.png?filename=nCD004136-CMP-002-05.ppt&amp;title=2.5&amp;caption=Comparison%202%20ARB%20versus%20placebo%2Fno%20treatment%2C%20Outcome%205%20Adverse%20events.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00206"><img data-id="CD004136-fig-00206" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-06.png" alt="Comparison 2 ARB versus placebo/no treatment, Outcome 6 Blood pressure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 ARB versus placebo/no treatment, Outcome 6 Blood pressure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00206" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-002-06.png?filename=nCD004136-CMP-002-06.ppt&amp;title=2.6&amp;caption=Comparison%202%20ARB%20versus%20placebo%2Fno%20treatment%2C%20Outcome%206%20Blood%20pressure.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-002-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00301"><img data-id="CD004136-fig-00301" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-003-01.png" alt="Comparison 3 ACEi versus ARB, Outcome 1 Normo‐ to micro‐ or macroalbuminuria."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 ACEi versus ARB, Outcome 1 Normo‐ to micro‐ or macroalbuminuria.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00301" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-003-01.png?filename=nCD004136-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20ACEi%20versus%20ARB%2C%20Outcome%201%20Normo%E2%80%90%20to%20micro%E2%80%90%20or%20macroalbuminuria.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-003-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00302"><img data-id="CD004136-fig-00302" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-003-02.png" alt="Comparison 3 ACEi versus ARB, Outcome 2 All‐cause mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 ACEi versus ARB, Outcome 2 All‐cause mortality.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00302" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-003-02.png?filename=nCD004136-CMP-003-02.ppt&amp;title=3.2&amp;caption=Comparison%203%20ACEi%20versus%20ARB%2C%20Outcome%202%20All%E2%80%90cause%20mortality.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-003-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00401"><img data-id="CD004136-fig-00401" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-01.png" alt="Comparison 4 ACEi versus CCB, Outcome 1 Normo to micro or macroalbuminuria."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 ACEi versus CCB, Outcome 1 Normo to micro or macroalbuminuria.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00401" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-004-01.png?filename=nCD004136-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20ACEi%20versus%20CCB%2C%20Outcome%201%20Normo%20to%20micro%20or%20macroalbuminuria.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00402"><img data-id="CD004136-fig-00402" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-02.png" alt="Comparison 4 ACEi versus CCB, Outcome 2 All‐cause mortality."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 ACEi versus CCB, Outcome 2 All‐cause mortality.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00402" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-004-02.png?filename=nCD004136-CMP-004-02.ppt&amp;title=4.2&amp;caption=Comparison%204%20ACEi%20versus%20CCB%2C%20Outcome%202%20All%E2%80%90cause%20mortality.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00403"><img data-id="CD004136-fig-00403" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-03.png" alt="Comparison 4 ACEi versus CCB, Outcome 3 Doubling of SCr."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 ACEi versus CCB, Outcome 3 Doubling of SCr.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00403" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-004-03.png?filename=nCD004136-CMP-004-03.ppt&amp;title=4.3&amp;caption=Comparison%204%20ACEi%20versus%20CCB%2C%20Outcome%203%20Doubling%20of%20SCr.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00404"><img data-id="CD004136-fig-00404" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-04.png" alt="Comparison 4 ACEi versus CCB, Outcome 4 ESKD."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 ACEi versus CCB, Outcome 4 ESKD.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00404" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-004-04.png?filename=nCD004136-CMP-004-04.ppt&amp;title=4.4&amp;caption=Comparison%204%20ACEi%20versus%20CCB%2C%20Outcome%204%20ESKD.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00405"><img data-id="CD004136-fig-00405" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-05.png" alt="Comparison 4 ACEi versus CCB, Outcome 5 Blood pressure."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 ACEi versus CCB, Outcome 5 Blood pressure.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00405" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-004-05.png?filename=nCD004136-CMP-004-05.ppt&amp;title=4.5&amp;caption=Comparison%204%20ACEi%20versus%20CCB%2C%20Outcome%205%20Blood%20pressure.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-004-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00501"><img data-id="CD004136-fig-00501" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-005-01.png" alt="Comparison 5 Prevention of kidney disease: other agents, Outcome 1 ACEi + ARB versus ACEi."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Prevention of kidney disease: other agents, Outcome 1 ACEi + ARB versus ACEi. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00501" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-005-01.png?filename=nCD004136-CMP-005-01.ppt&amp;title=5.1&amp;caption=Comparison%205%20Prevention%20of%20kidney%20disease%3A%20other%20agents%2C%20Outcome%201%20ACEi%20%2B%20ARB%20versus%20ACEi.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-005-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00502"><img data-id="CD004136-fig-00502" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-005-02.png" alt="Comparison 5 Prevention of kidney disease: other agents, Outcome 2 ACEi versus BB."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Prevention of kidney disease: other agents, Outcome 2 ACEi versus BB.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00502" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-005-02.png?filename=nCD004136-CMP-005-02.ppt&amp;title=5.2&amp;caption=Comparison%205%20Prevention%20of%20kidney%20disease%3A%20other%20agents%2C%20Outcome%202%20ACEi%20versus%20BB.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-005-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00503"><img data-id="CD004136-fig-00503" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-005-03.png" alt="Comparison 5 Prevention of kidney disease: other agents, Outcome 3 ACEi + CCB versus ACEi."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Prevention of kidney disease: other agents, Outcome 3 ACEi + CCB versus ACEi. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00503" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-005-03.png?filename=nCD004136-CMP-005-03.ppt&amp;title=5.3&amp;caption=Comparison%205%20Prevention%20of%20kidney%20disease%3A%20other%20agents%2C%20Outcome%203%20ACEi%20%2B%20CCB%20versus%20ACEi.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-005-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD004136-fig-00504"><img data-id="CD004136-fig-00504" src="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-005-04.png" alt="Comparison 5 Prevention of kidney disease: other agents, Outcome 4 CCB versus placebo."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Prevention of kidney disease: other agents, Outcome 4 CCB versus placebo.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-fig-00504" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/ppt/CDSR/CD004136/image_n/nCD004136-CMP-005-04.png?filename=nCD004136-CMP-005-04.ppt&amp;title=5.4&amp;caption=Comparison%205%20Prevention%20of%20kidney%20disease%3A%20other%20agents%2C%20Outcome%204%20CCB%20versus%20placebo.&amp;citation=Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GFM. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database of Systematic Reviews 2012, 12. Art. No.: CD004136. DOI: http://dx.doi.org/10.1002/14651858.CD004136.pub3"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD004136.pub3/media/CDSR/CD004136/image_n/nCD004136-CMP-005-04.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD004136-tbl-0006"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Guidelines on pharmacological management of hypertension in diabetic patients</span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Guideline</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Indication</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>ACEi</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>ARB</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>BB</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>CCB</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Diuretics</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>AB</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD004136-bbs2-0040">Chobanian 2003</a><sup>a</sup> <br> USA </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hypertension</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 1 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 2 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD004136-bbs2-0034">ADA 2010</a><sup>b</sup> </p> <p>USA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hypertension</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 1 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 2 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD004136-bbs2-0047">KDOQI 2007</a><sup>c</sup> <br> USA </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hypertension</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 1 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 2 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD004136-bbs2-0037">CDA 2008</a><sup>d</sup> <br> Canada </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hypertension<sup>h</sup> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 1 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 2 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes<sup>j</sup> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD004136-bbs2-0041">ESH‐ESC 2007</a><sup>e</sup> <br> Europe </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hypertension<sup>i</sup> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 1 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 2 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD004136-bbs2-0061">Williams 2004</a><sup>f</sup> <br> UK </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hypertension</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes<sup>l</sup> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 1 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 2 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p><a href="./references#CD004136-bbs2-0038">Chadban 2010</a><sup>g</sup> <br> Australia </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hypertension</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 1 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>DKD (type 2 diabetes)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>a</sup> Joint National Committee on Prevention, Diagnosis and Management of Hypertension; <sup>b</sup> American Diabetes Association; <sup>c</sup> Kidney Disease Outcome Quality Initiative; <sup>d</sup> Canadian Diabetes Association; <sup>e</sup> European Society of Hypertension; <sup>f</sup> British Hypertension Society; <sup>g</sup> Caring for Australians with Renal Impairment; <sup>h</sup> With special consideration given to ACEi or ARB; <sup>i</sup> A blocker of the renin‐angiotensin system should be a regular component of combination treatment and the one preferred when monotherapy is sufficient; <sup>j</sup> Consensus for ARB use in type 1 diabetes; <sup>k</sup>Use calcium antagonists for hypertension when can be managed with monotherapy; use any agent for hypertension which requires combination treatment; <sup>l</sup>If intolerant to other agents </p> <p>AB ‐ alpha‐blocker; ACEi ‐ angiotensin‐converting enzyme inhibitors; ARB ‐ angiotensin receptor blockers; BB ‐ beta‐blockers; CCB ‐ calcium channel blockers; DKD ‐ diabetic kidney disease </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Guidelines on pharmacological management of hypertension in diabetic patients</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full#CD004136-tbl-0006" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD004136-tbl-0007"> <div class="table-heading"><span class="table-label">Table 2.</span>&nbsp;<span class="table-title">Subgroup analysis of ACEi and ARB for preventing diabetic kidney disease</span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Variables</b> </p> </td> <td align="center" valign="" colspan="4" rowspan="1" bgcolor="#ffffff"> <p><b>ACEi versus placebo</b> </p> </td> <td align="center" valign="" colspan="4" rowspan="1" bgcolor="#ffffff"> <p><b>ARB versus placebo</b> </p> </td> <td align="center" valign="" colspan="4" rowspan="1" bgcolor="#ffffff"> <p><b>ACEi versus CCB</b> </p> </td> </tr> <tr> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Subgroup</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Studies</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Heterogeneity</b> </p> <p><b>(P)</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Subgroup</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Studies</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Heterogeneity</b> </p> <p><b>(P)</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Subgroup</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Studies</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>RR (95% CI)</b> </p> </td> <td align="center" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Heterogeneity</b> </p> <p><b>(P)</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Normoalbuminuria</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≥ 500</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.84 (0.79,0.90)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.023</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≥ 1500</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.86 (0.76,0.97)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.089</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≥ 300</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.57 (0.34,0.96)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.756</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; 500</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.36 (0.17,0.79)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; 1500</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.30 (0.49,3.45)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; 300</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.63 (0.38,1.04)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Event rate/100 person‐years</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≥ 5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.76 (0.54,1.07)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.059</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≥ 2.8</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.83 (0.73,0.94)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.035</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≥ 2.0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.57 (0.39,0.82)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.378</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; 5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.59 (0.41,0.85)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; 2.8</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.27 (0.79,2.03)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; 2.0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.01 (0.30,3.43)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Duration of follow‐up (years)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≥ 4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.76 (0.58,1.00)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.126</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≥ 4.8</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.27 (0.52,3.11)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.062</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≥ 3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.60 (0.38,0.94)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.973</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; 4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.60 (0.36,1.00)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; 4.8</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.84 (0.74,0.94)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; 3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.59 (0.34,1.04)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>Diabetes mellitus<sup>a</sup> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Type 1</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.54 (0.24,1.20)</p> </td> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>0.526</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Type 1</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.16 (0.79,1.70)</p> </td> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>0.048</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Type 1</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="3" bgcolor="#ffffff"> <p>Not estimated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Type 2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.67 (0.43,1.04)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Type 2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.83 (0.73,0.94)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Type 2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.60 (0.42, 0.85)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>mixed</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.71 (0.39,1.29)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mixed</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mixed</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Hypertension<sup>b</sup> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.64 (0.43,0.96)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.740</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.84 (0.75,0.95)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.127</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.60 (0.42, 0.85)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Not estimated</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.82 (0.73,0.92)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.06 (0.67,1.69)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Systolic BP (mm Hg)</p> <p>(difference between&nbsp;treatment/control)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≤ ‐3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.84 (0.79,0.90)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.075</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≤ ‐3.5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.85 (0.61, 1.18)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.259</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&gt; 0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.68 (0.43,1.07)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.420</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&gt; ‐3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.41 (0.15,1.08)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&gt; ‐3.5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.21 (0.72, 2.05)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≤ 0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.50 (0.29,0.87)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Diastolic BP (mm Hg)</p> <p>(difference between&nbsp;treatment/control)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≤ ‐2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.68 (0.50,0.92)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.175</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≤ ‐2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.94 (0.75, 1.18)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.828</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&gt; 0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.65 (0.39,1.08)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.651</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; ‐2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.61 (0.36,1.05)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; ‐2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.07 (0.66, 1.73)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≤ 0</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.55 (0.34,0.90)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Allocation concealment</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.84 (0.79,0.90)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.019</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.86 (0.77,0.96)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.047</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.01 (0.30,3.43)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.378</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.48 (0.29,0.79)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.96 (0.07,12.80)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.57 (0.34,0.82)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Intention‐to‐treat analysis</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.84 (0.79,0.90)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.019</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.88 (0.74,1.05)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.741</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Yes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.59 (0.34,1.04)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.973</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear/No</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.48 (0.29,0.79)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear/No</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.37 (0.45,4.14)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear/no</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.60 (0.38,0.94)</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>Lost to follow‐up</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; 1%</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.71 (0.44,1.16)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.075</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; 1%</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 (0.63,0.93)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.119</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>&lt; 1%</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.63 (0.38,1.04)</p> </td> <td align="" valign="" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>0.580</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≤ 1%</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.64 (0.48,0.86)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≤ 1%</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.99 (0.78,1.24)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>≤ 1%</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.57 (0.34,0.96)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="13"> <div class="table-footnote"> <p><sup>a</sup> TRANSCEND was split as type 1 and type 2 diabetes mellitus; <sup>b</sup> ADVANCE was split as hypertension and normotension </p> <p>ACEi ‐ angiotensin‐converting enzyme inhibitors; ARB ‐ angiotensin receptor blockers; CCB ‐ calcium channel blockers </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span>&nbsp;<span class="table-title">Subgroup analysis of ACEi and ARB for preventing diabetic kidney disease</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/full#CD004136-tbl-0007" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD004136-tbl-0001" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">ACEi versus placebo/no treatment</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Normo‐ to micro‐ or macroalbuminuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11906</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.71 [0.56, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11350</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.84 [0.73, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Doubling of SCr <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10749</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 [0.39, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 ESKD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10504</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.94 [0.66, 5.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Cough</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11791</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.84 [1.24, 2.72]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 Headache</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10504</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.19 [0.47, 3.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.3 Hyperkalaemia</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2783</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.98 [0.47, 18.78]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.1 Systolic BP</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7526</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐5.37 [‐7.12, ‐3.62]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.2 Diastolic BP</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7526</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.50 [‐1.50, ‐1.50]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">ACEi versus placebo/no treatment</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD004136-tbl-0002" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">ARB versus placebo/no treatment</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Normo‐ to micro‐ or macroalbuminuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7653</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.90 [0.68, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7653</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.12 [0.88, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Doubling of SCr <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6217</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.36 [0.64, 2.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 ESKD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6217</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.50 [0.09, 2.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Cough</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1770</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.01 [0.42, 2.44]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 Headache</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3191</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.52, 1.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.3 Hyperkalaemia</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3191</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.30 [0.69, 7.71]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.1 Systolic BP</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1770</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐3.28 [‐5.29, ‐1.27]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.2 Diastolic BP</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1770</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.0 [‐2.64, ‐1.36]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">ARB versus placebo/no treatment</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-tbl-0002" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD004136-tbl-0003" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">ACEi versus ARB</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Normo‐ to micro‐ or macroalbuminuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4303</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.57 [0.14, 2.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4303</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.02 [0.85, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">ACEi versus ARB</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-tbl-0003" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD004136-tbl-0004" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">ACEi versus CCB</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Normo to micro or macroalbuminuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1253</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.60 [0.42, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1519</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.84 [0.26, 2.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Doubling of SCr <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>607</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 ESKD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>680</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Blood pressure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Systolic BP</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>430</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.0 [1.59, 6.41]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 Diastolic BP</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>430</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.22 [‐0.42, 2.85]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">ACEi versus CCB</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-tbl-0004" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD004136-tbl-0005" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">Prevention of kidney disease: other agents</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 ACEi + ARB versus ACEi <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4171</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.88 [0.78, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 ACEi versus BB <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 ACEi + CCB versus ACEi <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 CCB versus placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">Prevention of kidney disease: other agents</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD004136.pub3/references#CD004136-tbl-0005" class="tableList">Navigate to table in Review</a></div> </div> </div> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD004136-note-1210">Español</a> </li> <li class="section-language"> <a class="" href="ja#CD004136-note-1209">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD004136-note-1206">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD004136-note-1207">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh#CD004136-note-1208">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_citeulike at300b btn btn-link">CiteULike</a></li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <h4>Copy or download citation</h4> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/">
<img class="footer-logo logo-part-1" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> <nav class="footer-links"> <ul class="root"> <li class="footer-item"> <a class="footer-item-link" href="/about-cochrane1">About Cochrane</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/evidence" target="_blank">Cochrane.org</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank">Who we are</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NJYXT5SPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Get involved</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX665WNWTYE63PMNYXG4DTMFYGKLUQPJUB/" target="_blank">Consumer Network</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-funders-and-partners" target="_blank">Partners</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYXZ5DQPF4XT7LNF3SX8Z5IPJRX63JPN73GH/" target="_blank">Colloquium</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news" target="_blank">In the news</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/publications">Publications</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="/library">Cochrane Library</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/" target="_blank">Library Homepage</a> </li> <li class="footer-item"> <a class="footer-item-link" href="cdsr/about-cdsr" target="_blank">Cochrane Reviews (CDSR)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/central" target="_blank">Trials (CENTRAL)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cca/about" target="_blank">Cochrane Clinical Answers</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/cochrane-library-app" target="_blank">Cochrane Library App</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cdsr/journal-club" target="_blank">Journal Club</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/podcasts" target="_blank">Podcasts</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/community">Community</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Community</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MF3GG4DJMVYGG55DNB3GC5UFF3YYE3D/" target="_blank">Archie log-in</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/PS3GC4LPNFYGPLUDN7SXR6UBN3TT655TMH/" target="_blank">Training and support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/NWTYI4DQMS3T6Z5QMNVHEZLPMVYG86UH/" target="_blank">Methods</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/help" target="_blank">Software</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news/jobs" target="_blank">Jobs and opportunities</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/contact-us">Contact Us</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/contact" target="_blank">General enquiries</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/help/contact-us" target="_blank">Cochrane Library support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/chief-executive-officers-office/team" target="_blank">Chief Executive Officer</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/editorial-methods/team" target="_blank">Editor in Chief</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-global-community" target="_blank">Cochrane groups</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/media" target="_blank">Media</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/accessibility" target="_blank">Accessibility</a> </li> </ul> </li> </ul> </nav> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2020 by <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUYNFXGK8JPMNYXN/" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUYNFXGK8JPMNYXN/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MW4T675JNSTYTLUDN7XB/"><img class="logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1581422282000" type="text/javascript"></script> <!--<![endif]--> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/theme.js?t=1581422282000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/checkout.js"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MN3G865UNWRYE43NMNTG6LUDPJYYG65TMWUC655TMH/widget/v2.0/widget.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MRZXE8DIHB4XC63SNWYHPN3PMNXG87LEM33G85UVF3YGK7A/assets/embed.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718153000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718249000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718249000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581718173000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004136\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004136\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004136\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004136\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004136\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581422282000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=EfT7x5RD&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004136.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004136.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD004136.pub3/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD004136.pub3/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004136.pub3%2Freferences" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1583244190557" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x2f;references" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1583244190561" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD004136&#x2e;pub3&#x2f;references" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD004136.pub3";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 